{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "def get_all_filenames(directory):\n",
    "\n",
    "    if not os.path.exists(directory):\n",
    "        raise FileNotFoundError(f\"The directory '{directory}' does not exist.\")\n",
    "    \n",
    "    # Get all files and exclude directories\n",
    "    filenames = [f for f in os.listdir(directory) if os.path.isfile(os.path.join(directory, f))]\n",
    "    return sorted(filenames)\n",
    "\n",
    "# Example usage\n",
    "directory_path = \"data/\"  # Replace with your directory path\n",
    "try:\n",
    "    filenames = get_all_filenames(directory_path)\n",
    "    print(\"Filenames in directory:\")\n",
    "    for filename in filenames:\n",
    "        rid = filename.split(\".\")[0]\n",
    "        print(rid)\n",
    "except Exception as e:\n",
    "    print(f\"Error: {e}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "## read all the most relevant papers by gpt-4 and keep it in a list or dict per year\n",
    "\n",
    "## read top-3 papers from llama and compute the precision or recall of relevant papers \n",
    "\n",
    "# Recall in this context measures the proportion of years where Llama's top-3 retrieved results include the GPT-4 most relevant paper (considered the ground truth)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "with open(\"../most_relevant_papers_llama.json\") as f:\n",
    "    llama = json.load(f)\n",
    "\n",
    "with open(\"../test_data_gpt4.json\") as f:\n",
    "    gpt4 = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "with open(\"../final_llama.json\") as f:\n",
    "    llama = json.load(f)\n",
    "\n",
    "with open(\"../test_data_gpt4.json\") as f:\n",
    "    gpt4 = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(dict_keys(['1. Indomethacin Prophylaxis Is Associated with Reduced Risk of Intraventricular Hemorrhage in Extremely Preterm Infants Born in the Context of Amniotic Infection Syndrome']),\n",
       " 'Indomethacin Prophylaxis Is Associated with Reduced Risk of Intraventricular Hemorrhage in Extremely Preterm Infants Born in the Context of Amniotic Infection Syndrome')"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gpt4['2023'].keys(), llama['2023']['title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "set()\n",
      "{'Indomethacin Prophylaxis Is Associated with Reduced Risk of Intraventricular Hemorrhage in Extremely Preterm Infants Born in the Context of Amniotic Infection Syndrome'}\n",
      "{'Reduction of Severe Intraventricular Hemorrhage in Preterm Infants: A Quality Improvement Project'}\n",
      "set()\n",
      "{'Indomethacin dosing strategy and neonatal patent ductus arteriosus closure'}\n",
      "{'Prevention, Reduction and Repair of Brain Injury of the Preterm Infant'}\n",
      "{'Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: A systematic review and meta-analysis of observational studies.'}\n",
      "{'Effect of Prophylactic Indomethacin in Extremely Low Birth Weight Infants Based on the Predicted Risk of Severe Intraventricular Hemorrhage'}\n",
      "{'Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants'}\n",
      "{'Placental transfusion at birth: do we have all of the answers?'}\n",
      "{'Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation'}\n",
      "{'Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.'}\n",
      "{'Fluid Restriction and Prophylactic Indomethacin in Extremely Low Birth Weight Infants'}\n",
      "{'Indomethacin prophylaxis revisited: changing practice and supportive'}\n",
      "{'Retinopathy of prematurity in very low birth weight infants and the potential protective role of indomethacin'}\n",
      "{'Patent Ductus Arteriosus Therapy: Impact on Neonatal and 18-Month Outcome'}\n",
      "{'Prevention and 18-Month Outcomes of Serious Pulmonary Hemorrhage in Extremely Low Birth Weight Infants: Results From the Trial of Indomethacin Prophylaxis in Preterms'}\n",
      "{'Prevention of Necrotizing Enterocolitis in Preterm Infants: A 20-Year Experience'}\n",
      "{\"Prolonged Indomethacin Exposure Is Associated With Decreased White Matter Injury Detected With Magnetic Resonance Imaging in Premature Newborns at 24 to 28 Weeks' Gestation at Birth\"}\n",
      "{'Patent Ductus Arteriosus, Indomethacin and Necrotizing Enterocolitis in Very Low Birth Weight Infants: A Population-Based Study'}\n",
      "{'Age-dependent cerebral hemodynamic effects of indomethacin in the newborn piglet'}\n",
      "{'Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms'}\n",
      "{\"Evaluating 'old' definitions for the 'new' bronchopulmonary dysplasia\"}\n",
      "Hit Rate (GPT-4 in LLaMA): 0.35\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "\n",
    "def remove_numbering(title):\n",
    "    return re.sub(r'^\\d+\\.\\s*', '', title)\n",
    "\n",
    "def compute_hit_rate_gpt4_in_llama(llama, gpt4):\n",
    "    total_years = len(gpt4)\n",
    "    hit_years = 0\n",
    "\n",
    "    for year, gpt4_titles in gpt4.items():\n",
    "        llama_titles = set()\n",
    "        if year in llama:\n",
    "            llama_entries = llama[year]  # Retrieve entries for the year\n",
    "            if 'title' in llama_entries:\n",
    "                llama_titles = {llama_entries['title']}\n",
    "        \n",
    "        print(llama_titles)\n",
    "\n",
    "        normalized_gpt4_titles = {remove_numbering(title) for title in gpt4_titles}\n",
    "\n",
    "        # Check if there's any overlap\n",
    "        if normalized_gpt4_titles.intersection(llama_titles):\n",
    "            hit_years += 1\n",
    "\n",
    "    # Calculate the hit rate\n",
    "    hit_rate = hit_years / total_years if total_years > 0 else 0\n",
    "    print(f\"Hit Rate (GPT-4 in LLaMA): {hit_rate:.2f}\")\n",
    "    return hit_rate\n",
    "\n",
    "\n",
    "# Example usage\n",
    "hit_rate_gpt4_in_llama = compute_hit_rate_gpt4_in_llama(llama, gpt4)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[]\n"
     ]
    },
    {
     "ename": "SystemExit",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "An exception has occurred, use %tb to see the full traceback.\n",
      "\u001b[0;31mSystemExit\u001b[0m\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "import sys\n",
    "\n",
    "def remove_numbering(title):\n",
    "    return re.sub(r'^\\d+\\.\\s*', '', title)\n",
    "\n",
    "def compute_hit_rate_gpt4_in_llama(llama, gpt4):\n",
    "    total_years = len(gpt4)\n",
    "    hit_years = 0\n",
    "\n",
    "    for year in gpt4.keys():\n",
    "        print(llama.get(2023, []))\n",
    "        sys.exit()\n",
    "        llama_titles = set(map(remove_numbering, llama.get(year, []))) \n",
    "        gpt4_titles = set(map(remove_numbering, gpt4[year]))  \n",
    "\n",
    "        if gpt4_titles.intersection(llama_titles):  \n",
    "            hit_years += 1\n",
    "\n",
    "    hit_rate = hit_years / total_years if total_years > 0 else 0\n",
    "    print(f\"Hit Rate (GPT-4 in LLaMA): {hit_rate:.2f}\")\n",
    "    return hit_rate\n",
    "\n",
    "hit_rate_gpt4_in_llama = compute_hit_rate_gpt4_in_llama(llama, gpt4)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Hit Rate (GPT-4 in LLaMA): 0.61\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "\n",
    "def remove_numbering(title):\n",
    "    return re.sub(r'^\\d+\\.\\s*', '', title)\n",
    "\n",
    "def compute_hit_rate_gpt4_in_llama(llama, gpt4):\n",
    "    total_years = len(gpt4)\n",
    "    hit_years = 0\n",
    "\n",
    "    for year in gpt4.keys():\n",
    "        llama_titles = set(map(remove_numbering, llama.get(year, []))) \n",
    "        gpt4_titles = set(map(remove_numbering, gpt4[year]))  \n",
    "\n",
    "        if gpt4_titles.intersection(llama_titles):  \n",
    "            hit_years += 1\n",
    "\n",
    "    hit_rate = hit_years / total_years if total_years > 0 else 0\n",
    "    print(f\"Hit Rate (GPT-4 in LLaMA): {hit_rate:.2f}\")\n",
    "    return hit_rate\n",
    "\n",
    "hit_rate_gpt4_in_llama = compute_hit_rate_gpt4_in_llama(llama, gpt4)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import json\n",
    "import sys\n",
    "sys.path.append('/srv/scratch1/rosni/scigen/')\n",
    "import os\n",
    "import re\n",
    "import time\n",
    "import openai\n",
    "from openai import OpenAI\n",
    "openai.api_key = os.environ[\"OPENAI_API_KEY\"]\n",
    "SEMANTIC_SCHOLAR_API_KEY = os.environ.get(\"S2_API_KEY\", None)\n",
    "import tiktoken\n",
    "from transformers import pipeline\n",
    "import torch\n",
    "\n",
    "def get_citings_by_id(paper_id):\n",
    "    url = f'https://api.semanticscholar.org/graph/v1/paper/{paper_id}/citations'\n",
    "    # Specify the fields you are interested in\n",
    "    params = {\n",
    "        \"fields\": \"abstract,contexts,intents,isInfluential,year,title\",\n",
    "        \"offset\": 0,\n",
    "        \"limit\": 1000\n",
    "    }\n",
    "    # Include API key in headers if needed\n",
    "    api_key = os.environ.get(\"S2_API_KEY\", None)\n",
    "    headers = {\n",
    "        'x-api-key': api_key  # Replace 'your_api_key_here' with your actual API key\n",
    "    }\n",
    "    max_retries = 3\n",
    "    backoff_factor = 2\n",
    "    \n",
    "    for attempt in range(max_retries):\n",
    "        response = requests.get(url, params=params, headers=headers)\n",
    "        if response.status_code == 200:\n",
    "            return response.json()\n",
    "        else:\n",
    "            print(f'Attempt {attempt + 1} failed: Status code {response.status_code}')\n",
    "            time.sleep(backoff_factor * (2 ** attempt))  # Exponential backoff\n",
    "\n",
    "    print(\"Failed to fetch data after retries.\")\n",
    "    return None\n",
    "\n",
    "def get_paper_by_id(paper_id):\n",
    "    url = f'https://api.semanticscholar.org/graph/v1/paper/{paper_id}'\n",
    "    # Specify the fields you are interested in\n",
    "    params = {\n",
    "        'fields': 'externalIds,title,year,citationCount,abstract,citations.title,citations.year,citations.paperId,citations.citationCount,citations.abstract'\n",
    "    }\n",
    "    # Include API key in headers if needed\n",
    "    api_key = os.environ.get(\"S2_API_KEY\", None)\n",
    "    headers = {\n",
    "        'x-api-key': api_key  # Replace 'your_api_key_here' with your actual API key\n",
    "    }\n",
    "    max_retries = 3\n",
    "    backoff_factor = 2\n",
    "    \n",
    "    for attempt in range(max_retries):\n",
    "        response = requests.get(url, params=params, headers=headers)\n",
    "        if response.status_code == 200:\n",
    "            return response.json()\n",
    "        else:\n",
    "            print(f'Attempt {attempt + 1} failed: Status code {response.status_code}')\n",
    "            time.sleep(backoff_factor * (2 ** attempt))  # Exponential backoff\n",
    "\n",
    "    print(\"Failed to fetch data after retries.\")\n",
    "    return None\n",
    "\n",
    "def get_paper_data(paper_id):\n",
    "    url = f'https://api.semanticscholar.org/graph/v1/paper/{paper_id}'\n",
    "    # Specify the fields you are interested in\n",
    "    params = {\n",
    "        'fields': 'externalIds,title,year,citationCount,abstract'\n",
    "    }\n",
    "    # Include API key in headers if needed\n",
    "    api_key = os.environ.get(\"S2_API_KEY\", None)\n",
    "    headers = {\n",
    "        'x-api-key': api_key  # Replace 'your_api_key_here' with your actual API key\n",
    "    }\n",
    "    max_retries = 3\n",
    "    backoff_factor = 2\n",
    "    \n",
    "    for attempt in range(max_retries):\n",
    "        response = requests.get(url, params=params, headers=headers)\n",
    "        if response.status_code == 200:\n",
    "            return response.json()\n",
    "        else:\n",
    "            print(f'Attempt {attempt + 1} failed: Status code {response.status_code}')\n",
    "            time.sleep(backoff_factor * (2 ** attempt))  # Exponential backoff\n",
    "\n",
    "    print(\"Failed to fetch data after retries.\")\n",
    "    return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'paperId': '264f5d9813ea623d28f0825cb9b56e8e9e8e66e9',\n",
       " 'externalIds': {'MAG': '1970964364',\n",
       "  'DOI': '10.1111/j.1651-2227.1987.tb17260.x',\n",
       "  'CorpusId': 20418406,\n",
       "  'PubMed': '3321891'},\n",
       " 'title': 'Early Intravenous Indomethacin Prolongs Respiratory Support in Very Low Birth Weight Infants',\n",
       " 'abstract': 'ABSTRACT. Infants weighing 1500 g at birth requiring either intermittent positive pressure ventilation or continuous positive airway pressure by 12 hours of age were entered in a randomized double blind controlled trial to test the efficacy of early intravenous indomethacin therapy in preventing chronic pulmonary disease of prematurity. Of the 30 newborns enrolled, 15 were treated with indomethacin and 15 were treated with placebo at 12, 24 and 36 hours of age. The groups were similar for birth weight, gestational age, sex, hyaline membrane disease and intracranial hemorrhage. Infants in the placebo group were successfully weaned from intermittent positive pressure ventilation at an earlier age than infants in the indomethacin group (p <0.05). Furthermore, chronic pulmonary disease of prematurity was similar in the two groups despite a reduction in the incidence of patent ductus arteriosus in the indomethacin group.',\n",
       " 'year': 1987,\n",
       " 'citationCount': 39,\n",
       " 'citations': [{'paperId': 'db362d5c44606622612eeb0d29d6f8e3960f0297',\n",
       "   'title': 'Interventions to Reduce Severe Brain Injury Risk in Preterm Neonates',\n",
       "   'abstract': 'This systematic review and meta-analysis examines the role of perinatal interventions in the development of severe intraventricular hemorrhage and cystic periventricular leukomalacia in neonates born before 37 weeks’ gestation.',\n",
       "   'year': 2023,\n",
       "   'citationCount': 14},\n",
       "  {'paperId': 'facb785325b0a384b29b9aa18048546c59cd7ca3',\n",
       "   'title': 'Use of Prophylactic Indomethacin in Preterm Infants: A Systematic Review and Meta-Analysis',\n",
       "   'abstract': 'Background Prophylactic indomethacin has been widely used as an effective intervention for reducing mortalities and morbidities in preterm infants including the cardiopulmonary and neurodevelopmental morbidities such as intraventricular hemorrhage (IVH), but many studies have reported contradictory outcomes regarding its significance. Therefore, we aim to systematically review and meta-analyze the data of prophylactic indomethacin on preterm infants. Methods Our systematic search included the following databases: Pubmed, Google Scholar, Scopus, Web of Science, The New York Academy of Medicine (NYAM), Virtual health library (VHL), and the System for Information on Grey Literature in Europe (SIGLE) to include studies that assessed the use of prophylactic indomethacin in preterm infants until 12 August 2021. Results The final list of our included studies is comprised of 23 randomized trials and cohort studies. Among all the studies outcomes, significant favorable outcome was lowering the rate of PDA, surgical PDA ligation (P < 0.001) and severe IVH (P = 0.008) while no significance was recorded with BPD, pulmonary hemorrhage, intraventricular hemorrhage, necrotizing enterocolitis, intestinal perforation, mortality, and length of hospital stay. Conclusion Since the meta-analysis results regarding effectiveness of prophylactic indomethacin varied based on the study design particularly with regard to outcomes such as surgical PDA ligation and severe IVH, this warrants the need for more evidence regarding the effectiveness of prophylactic indomethacin in very low birth weight infants.',\n",
       "   'year': 2022,\n",
       "   'citationCount': 2},\n",
       "  {'paperId': '2f95469eb08a12ff4bab52939a9edf0b9c68f9a2',\n",
       "   'title': 'Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis.',\n",
       "   'abstract': \"BACKGROUND\\nPatent ductus arteriosus (PDA) is associated with significant morbidity and mortality in preterm infants. Cyclooxygenase inhibitors (COX-I) may prevent PDA-related complications. Controversy exists on which COX-I drug is the most effective and has the best safety profile in preterm infants.\\n\\n\\nOBJECTIVES\\nTo compare the effectiveness and safety of prophylactic COX-I drugs and 'no COXI prophylaxis' in preterm infants using a Bayesian network meta-analysis (NMA).\\n\\n\\nSEARCH METHODS\\nSearches of Cochrane CENTRAL via Wiley, OVID MEDLINE and Embase via Elsevier were conducted on 9 December 2021. We conducted independent searches of clinical trial registries and conference abstracts; and scanned the reference lists of included trials and related systematic reviews.\\n\\n\\nSELECTION CRITERIA\\nWe included randomised controlled trials (RCTs) that enrolled preterm or low birth weight infants within the first 72 hours of birth without a prior clinical or echocardiographic diagnosis of PDA and compared prophylactic administration of indomethacin or ibuprofen or acetaminophen versus each other, placebo or no treatment.\\n\\n\\nDATA COLLECTION AND ANALYSIS\\nWe used the standard methods of Cochrane Neonatal. We used the GRADE NMA approach to assess the certainty of evidence derived from the NMA for the following outcomes: severe intraventricular haemorrhage (IVH), mortality, surgical or interventional PDA closure, necrotizing enterocolitis (NEC), gastrointestinal perforation, chronic lung disease (CLD) and cerebral palsy (CP).\\n\\n\\nMAIN RESULTS\\nWe included 28 RCTs (3999 preterm infants). Nineteen RCTs (n = 2877) compared prophylactic indomethacin versus placebo/no treatment, 7 RCTs (n = 914) compared prophylactic ibuprofen versus placebo/no treatment and 2 RCTs (n = 208) compared prophylactic acetaminophen versus placebo/no treatment. Nine RCTs were judged to have high risk of bias in one or more domains.We identified two ongoing trials on prophylactic acetaminophen. Bayesian random-effects NMA demonstrated that prophylactic indomethacin probably led to a small reduction in severe IVH (network RR 0.66, 95% Credible Intervals [CrI] 0.49 to 0.87; absolute risk difference [ARD] 43 fewer [95% CrI, 65 fewer to 16 fewer] per 1000; median rank 2, 95% CrI 1-3; moderate-certainty), a moderate reduction in mortality (network RR 0.85, 95% CrI 0.64 to 1.1; ARD 24 fewer [95% CrI, 58 fewer to 16 more] per 1000; median rank 2, 95% CrI 1-4; moderate-certainty) and surgical PDA closure (network RR 0.40, 95% CrI 0.14 to 0.66; ARD 52 fewer [95% CrI, 75 fewer to 30 fewer] per 1000; median rank 2, 95% CrI 1-2; moderate-certainty) compared to placebo. Prophylactic indomethacin resulted in trivial difference in NEC (network RR 0.76, 95% CrI 0.35 to 1.2; ARD 16 fewer [95% CrI, 42 fewer to 13 more] per 1000; median rank 2, 95% CrI 1-3; high-certainty), gastrointestinal perforation (network RR 0.92, 95% CrI 0.11 to 3.9; ARD 4 fewer [95% CrI, 42 fewer to 137 more] per 1000; median rank 1, 95% CrI 1-3; moderate-certainty) or CP (network RR 0.97, 95% CrI 0.44 to 2.1; ARD 3 fewer [95% CrI, 62 fewer to 121 more] per 1000; median rank 2, 95% CrI 1-3; low-certainty) and may result in a small increase in CLD (network RR 1.10, 95% CrI 0.93 to 1.3; ARD 36 more [95% CrI, 25 fewer to 108 more] per 1000; median rank 3, 95% CrI 1-3; low-certainty). Prophylactic ibuprofen probably led to a small reduction in severe IVH (network RR 0.69, 95% CrI 0.41 to 1.14; ARD 39 fewer [95% CrI, 75 fewer to 18 more] per 1000; median rank 2, 95% CrI 1-4; moderate-certainty) and moderate reduction in surgical PDA closure (network RR 0.24, 95% CrI 0.06 to 0.64; ARD 66 fewer [95% CrI, from 82 fewer to 31 fewer] per 1000; median rank 1, 95% CrI 1-2; moderate-certainty) compared to placebo. Prophylactic ibuprofen may result in moderate reduction in mortality (network RR 0.83, 95% CrI 0.57 to 1.2; ARD 27 fewer [95% CrI, from 69 fewer to 32 more] per 1000; median rank 2, 95% CrI 1-4; low-certainty) and leads to trivial difference in NEC (network RR 0.73, 95% CrI 0.31 to 1.4; ARD 18 fewer [95% CrI, from 45 fewer to 26 more] per 1000; median rank 1, 95% CrI 1-3; high-certainty), or CLD (network RR 1.00, 95% CrI 0.83 to 1.3; ARD 0 fewer [95% CrI, from 61 fewer to 108 more] per 1000; median rank 2, 95% CrI 1-3; low-certainty). The evidence is very uncertain on effect of ibuprofen on gastrointestinal perforation (network RR 2.6, 95% CrI 0.42 to 20.0; ARD 76 more [95% CrI, from 27 fewer to 897 more] per 1000; median rank 3, 95% CrI 1-3; very low-certainty). The evidence is very uncertain on the effect of prophylactic acetaminophen on severe IVH (network RR 1.17, 95% CrI 0.04 to 55.2; ARD 22 more [95% CrI, from 122 fewer to 1000 more] per 1000; median rank 4, 95% CrI 1-4; very low-certainty), mortality (network RR 0.49, 95% CrI 0.16 to 1.4; ARD 82 fewer [95% CrI, from 135 fewer to 64 more] per 1000; median rank 1, 95% CrI 1-4; very low-certainty), or CP (network RR 0.36, 95% CrI 0.01 to 6.3; ARD 70 fewer [95% CrI, from 109 fewer to 583 more] per 1000; median rank 1, 95% CrI 1-3; very low-certainty). In summary, based on ranking statistics, both indomethacin and ibuprofen were equally effective (median ranks 2 respectively) in reducing severe IVH and mortality. Ibuprofen (median rank 1) was more effective than indomethacin in reducing surgical PDA ligation (median rank 2). However, no statistically-significant differences were observed between the COX-I drugs for any of the relevant outcomes.\\n\\n\\nAUTHORS' CONCLUSIONS\\nProphylactic indomethacin probably results in a small reduction in severe IVH and moderate reduction in mortality and surgical PDA closure (moderate-certainty), may result in a small increase in CLD (low-certainty) and results in trivial differences in NEC (high-certainty), gastrointestinal perforation (moderate-certainty) and cerebral palsy (low-certainty). Prophylactic ibuprofen probably results in a small reduction in severe IVH and moderate reduction in surgical PDA closure (moderate-certainty), may result in a moderate reduction in mortality (low-certainty) and trivial differences in CLD (low-certainty) and NEC (high-certainty). The evidence is very uncertain about the effect of acetaminophen on any of the clinically-relevant outcomes.\",\n",
       "   'year': 2022,\n",
       "   'citationCount': 2},\n",
       "  {'paperId': '1edf45b7fb44431e9207928878020059d93e5959',\n",
       "   'title': 'Patent ductus arteriosus management and the drift towards therapeutic nihilism - What is the evidence?',\n",
       "   'abstract': None,\n",
       "   'year': 2021,\n",
       "   'citationCount': 12},\n",
       "  {'paperId': 'e0e5a22be3a65d388c6faf786222181d33ccaa0b',\n",
       "   'title': 'Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis',\n",
       "   'abstract': 'Context: There is an ongoing debate on the optimal management of patent ductus arteriosus (PDA) in preterm infants. Identifying subgroup of infants who would benefit from pharmacological treatment might help. Objective: To investigate the modulating effect of the differences in methodological quality, the rate of open-label treatment, and patient characteristics on relevant outcome measures in randomized controlled trials (RCTs). Data Sources: Electronic database search between 1950 and May 2020. Study Selection: RCTs that assessed pharmacological treatment compared to placebo/no treatment. Data Extraction: Data is extracted following the PRISMA guidelines. Outcome measures were failure to ductal closure, surgical ligation, incidence of necrotizing enterocolitis, bronchopulmonary dysplasia, sepsis, periventricular leukomalacia, intraventricular hemorrhage (IVH) grade ≥3, retinopathy of prematurity and mortality. Results: Forty-seven studies were eligible. The incidence of IVH grade ≥3 was lower in the treated infants compared to the placebo/no treatment (RR 0.77, 95% CI 0.64–0.94) and in the subgroups of infants with either a gestational age <28 weeks (RR 0.77, 95% CI 0.61–0.98), a birth weight <1,000 g (RR 0.77, 95% CI 0.61–0.97), or if untargeted treatment with indomethacin was started <24 h after birth (RR 0.70, 95% CI 0.54–0.90). Limitations: Statistical heterogeneity caused by missing data and variable definitions of outcome parameters. Conclusions: Although the quality of evidence is low, this meta-analysis suggests that pharmacological treatment of PDA reduces severe IVH in extremely preterm, extremely low birth weight infants or if treatment with indomethacin was started <24 h after birth. No other beneficial effects of pharmacological treatment were found.',\n",
       "   'year': 2021,\n",
       "   'citationCount': 16},\n",
       "  {'paperId': 'fc3496d274cf826312ee740ca66b1d7bfed1082c',\n",
       "   'title': 'Does crossover treatment of control subjects invalidate results of randomized trials of patent ductus arteriosus treatment?',\n",
       "   'abstract': None,\n",
       "   'year': 2020,\n",
       "   'citationCount': 6},\n",
       "  {'paperId': 'f1cd7bd489b99a43cc324389662f2a53cf7be5eb',\n",
       "   'title': 'Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews',\n",
       "   'abstract': \"Abstract Background Patent ductus arteriosus (PDA) is associated with significant morbidity and mortality in preterm infants. Several non‐pharmacological, pharmacological, and surgical approaches have been explored to prevent or treat a PDA. Objectives To summarise Cochrane Neonatal evidence on interventions (pharmacological or surgical) for the prevention of PDA and related complications, and interventions for the management of asymptomatic and symptomatic PDA in preterm infants. Methods We searched the Cochrane Database of Systematic Reviews on 20 October 2022 for ongoing and published Cochrane Reviews on the prevention and treatment of PDA in preterm (< 37 weeks' gestation) or low birthweight (< 2500 g) infants. We included all published Cochrane Reviews assessing the following categories of interventions: pharmacological therapy using prostaglandin inhibitor drugs (indomethacin, ibuprofen, and acetaminophen), adjunctive pharmacological interventions, invasive PDA closure procedures, and non‐pharmacological interventions. Two overview authors independently checked the eligibility of the reviews retrieved by the search, and extracted data from the included reviews using a predefined data extraction form. Any disagreements were resolved by discussion with a third overview author. Two overview authors independently assessed the methodological quality of the included reviews using the AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) tool. We reported the GRADE certainty of evidence as assessed by the respective review authors using summary of findings tables. Main results We included 16 Cochrane Reviews, corresponding to 138 randomised clinical trials (RCT) and 11,856 preterm infants, on the prevention and treatment of PDA in preterm infants. One of the 16 reviews had no included studies, and therefore, did not contribute to the results. Six reviews reported on prophylactic interventions for the prevention of PDA and included pharmacological prophylaxis with prostaglandin inhibitor drugs, prophylactic surgical PDA ligation, and non‐pharmacologic interventions (chest shielding during phototherapy and restriction of fluid intake); one review reported on the use of indomethacin for the management of asymptomatic PDA; nine reviews reported on interventions for the management of symptomatic PDA, and included pharmacotherapy with prostaglandin inhibitor drugs in various routes and dosages, surgical PDA ligation, and adjunct therapies (use of furosemide and dopamine in conjunction with indomethacin). The quality of reviews varied. Two reviews were assessed to be high quality, seven reviews were of moderate quality, five of low quality, while two reviews were deemed to be of critically low quality. For prevention of PDA, prophylactic indomethacin reduces severe intraventricular haemorrhage (IVH; relative risk (RR) 0.66, 95% confidence interval (CI) 0.53 to 0.82; 14 RCTs, 2588 infants), and the need for invasive PDA closure (RR 0.51, 95% CI 0.37 to 0.71; 8 RCTs, 1791 infants), but it does not appear to affect the composite outcome of death or moderate/severe neurodevelopmental disability (RR 1.02, 95% CI 0.90 to 1.15; 3 RCTs, 1491 infants). Prophylactic ibuprofen probably marginally reduces severe IVH (RR 0.67, 95% CI 0.45 to 1.00; 7 RCTs, 925 infants; moderate‐certainty evidence), and the need for invasive PDA closure (RR 0.46, 95% CI 0.22 to 0.96; 7 RCTs, 925 infants; moderate‐certainty evidence). The evidence is very uncertain on the effect of prophylactic acetaminophen on severe IVH (RR 1.09, 95% CI 0.07 to 16.39; 1 RCT, 48 infants). Necrotising enterocolitis (NEC) was lower with both prophylactic surgical ligation (RR 0.25, 95% CI 0.08 to 0.83; 1 RCT, 84 infants), and fluid restriction (RR 0.43, 95% CI 0.21 to 0.87; 4 RCTs, 526 infants). For treatment of asymptomatic PDA, indomethacin appears to reduce the development of symptomatic PDA post‐treatment (RR 0.36, 95% CI 0.19 to 0.68; 3 RCTs, 97 infants; quality of source review: critically low). For treatment of symptomatic PDA, all available prostaglandin inhibitor drugs appear to be more effective in closing a PDA than placebo or no treatment (indomethacin: RR 0.30, 95% CI 0.23 to 0.38; 10 RCTs, 654 infants; high‐certainty evidence; ibuprofen: RR 0.62, 95% CI 0.44 to 0.86; 2 RCTs, 206 infants; moderate‐certainty evidence; early administration of acetaminophen: RR 0.35, 95% CI 0.23 to 0.53; 2 RCTs, 127 infants; low‐certainty evidence). Oral ibuprofen appears to be more effective in PDA closure than intravenous (IV) ibuprofen (RR 0.38, 95% CI 0.26 to 0.56; 5 RCTs, 406 infants; moderate‐certainty evidence). High‐dose ibuprofen appears to be more effective in PDA closure than standard‐dose ibuprofen (RR 0.37, 95% CI 0.22 to 0.61; 3 RCTs, 190 infants; moderate‐certainty evidence). With respect to adverse outcomes, compared to indomethacin administration, NEC appears to be lower with ibuprofen (any route; RR 0.68, 95% CI 0.49 to 0.94; 18 RCTs, 1292 infants; moderate‐certainty evidence), oral ibuprofen (RR 0.41, 95% CI 0.23 to 0.73; 7 RCTs, 249 infants; low‐certainty evidence), and with acetaminophen (RR 0.42, 95% CI 0.19 to 0.96; 4 RCTs, 384 infants; low‐certainty evidence). However, NEC appears to be increased with a prolonged course of indomethacin versus a shorter course (RR 1.87, 95% CI 1.07 to 3.27; 4 RCTs, 310 infants). Authors' conclusions This overview summarised the evidence from 16 Cochrane Reviews of RCTs regarding the effects of interventions for the prevention and treatment of PDA in preterm infants. Prophylactic indomethacin reduces severe IVH, but does not appear to affect the composite outcome of death or moderate/severe neurodevelopmental disability. Prophylactic ibuprofen probably marginally reduces severe IVH (moderate‐certainty evidence), while the evidence is very uncertain on the effect of prophylactic acetaminophen on severe IVH. All available prostaglandin inhibitor drugs appear to be effective in symptomatic PDA closure compared to no treatment (high‐certainty evidence for indomethacin; moderate‐certainty evidence for ibuprofen; low‐certainty evidence for early administration of acetaminophen). Oral ibuprofen appears to be more effective in PDA closure than IV ibuprofen (moderate‐certainty evidence). High dose ibuprofen appears to be more effective in PDA closure than standard‐dose ibuprofen (moderate‐certainty evidence). There are currently two ongoing reviews, one on fluid restriction for symptomatic PDA, and the other on invasive management of PDA in preterm infants.\",\n",
       "   'year': 2020,\n",
       "   'citationCount': 24},\n",
       "  {'paperId': 'a9224e7e1cca2d4d9652970379b3d51e9e67fd2a',\n",
       "   'title': 'Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia',\n",
       "   'abstract': 'Patent ductus arteriosus (PDA) is prevalent in premature newborns and has been linked to the development of bronchopulmonary dysplasia (BPD), a serious pulmonary complication of premature birth. Although a causal relationship has not been proven, the link is greatest among infants born at lower gestational age who are treated with mechanical ventilation in the presence of a large ductal shunt. Despite strong association in epidemiological studies, treatment of a patent ductus arteriosus has not been shown to prevent BPD, and some therapies may increase the risk of BPD. We describe preclinical and clinical data demonstrating the association of a PDA with BPD, highlight the effects of surgical and pharmacological treatment, and explore the implications of recent clinical trials for the management of PDA in the premature newborn.',\n",
       "   'year': 2018,\n",
       "   'citationCount': 30},\n",
       "  {'paperId': '703094c8c285c1fbef2e2965df969c0d42fee8a6',\n",
       "   'title': 'Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)',\n",
       "   'abstract': None,\n",
       "   'year': 2018,\n",
       "   'citationCount': 66},\n",
       "  {'paperId': 'd73cdb2bd90c54a7855b53790f83423a2f67d205',\n",
       "   'title': 'The use of non-steroidal anti-inflammatory drugs for patent ductus arteriosus closure in preterm infants.',\n",
       "   'abstract': None,\n",
       "   'year': 2017,\n",
       "   'citationCount': 41},\n",
       "  {'paperId': 'ef0c8f18a3aeba564835fe1df8fa5125b8741e6f',\n",
       "   'title': 'Prophylactic Indomethacin Worsens Short-Term Respiratory Outcomes in Extremely Low-Birth-Weight Infants',\n",
       "   'abstract': 'Abstract Objective\\u2003To compare the effects of prophylactic indomethacin versus expectant management on short-term respiratory outcomes in extremely low-birth-weight (ELBW) infants. Methods\\u2003This was a retrospective cohort study of ELBW infants with gestational age less than 28 weeks, born at a level III neonatal intensive care unit from 2004 to 2009. Patients were grouped based on whether they received prophylactic indomethacin or expectant treatment. The key outcome was the cumulative number of days of mechanical ventilation. Other outcomes were cumulative number of days supplemental oxygen and continuous positive airway pressure (CPAP) were required; duration of hospital stay; mortality; and other morbidities such as necrotizing enterocolitis and intraventricular hemorrhage. Multivariable linear regression was performed with treatment group and seven covariates, defined a priori, as predictor variables and cumulative number of days of mechanical ventilation as the outcome. Results\\u2003There were 144 infants in the prophylaxis group and 221 infants in the expectant treatment group. At baseline, the Score for Neonatal Acute Physiology–Perinatal Extension, incidence of respiratory distress syndrome, and usage of antenatal corticosteroids were significantly higher in the prophylaxis group. The cumulative number of days of mechanical ventilation, supplemental oxygen, and CPAP were significantly higher in the prophylaxis group. On multivariable linear regression, after adjusting for confounders, use of prophylactic indomethacin (unstandardized β coefficient\\u2009=\\u200912.4; 95% confidence interval [CI]: 6.6, 18.1; p\\u2009<\\u20090.001), birth weight (β\\u2009=\\u2009\\u2009−0.025; 95% CI: −0.05, −0.001; p\\u2009=\\u20090.043), and gestation (β\\u2009=\\u2009\\u2009−4.5; 95% CI: −7.24, −1.8; p\\u2009=\\u20090.001) were the independent predictors of cumulative number of days of mechanical ventilation. Conclusion\\u2003ELBW infants who received prophylactic indomethacin had significantly longer cumulative number of days of mechanical ventilation, supplemental oxygen, and CPAP. Prophylactic indomethacin is an independent predictor of cumulative number of days of mechanical ventilation.',\n",
       "   'year': 2013,\n",
       "   'citationCount': 8},\n",
       "  {'paperId': 'a3c6dd24cfa220d338d5f4ee9e8c119f1617e39f',\n",
       "   'title': 'Patent Ductus Arteriosus and the Lung',\n",
       "   'abstract': None,\n",
       "   'year': 2012,\n",
       "   'citationCount': 0},\n",
       "  {'paperId': '72be9c76a01754c8187d31d978021b874ce73269',\n",
       "   'title': 'Patent ductus arteriosus: to treat or not to treat?',\n",
       "   'abstract': 'Persistent patency of the ductus arteriosus in the preterm infant is associated with numerous morbidities, including higher rates of bronchopulmonary dysplasia and increased mortality. These strong associations have led to widespread use of cyclooxygenase inhibitors and surgical ligation to achieve ductal closure in the expectation that closing the ductus will reduce these complications. Each of these interventions has its own associated adverse effects. Neither individual randomised controlled trials nor meta-analyses of those trials have been able to demonstrate long-term benefits of these treatments despite their efficacy in inducing ductal closure and reducing the need for ductal ligation. Despite the potential shortcomings of those trials, they provide substantial cumulative evidence that early, routine treatment to close a persistently patent ductus arteriosus in preterm infants does not improve outcomes and should therefore be abandoned. Future trials of these interventions for patent ductus management should address different questions. Persistence of ductal patency should be considered a sign of rather than a direct cause of the several morbidities with which it is clearly associated. Practitioners should tolerate ductal patency and learn to manage its causes and consequences rather than focusing on achievement of ductal closure.',\n",
       "   'year': 2011,\n",
       "   'citationCount': 101},\n",
       "  {'paperId': '9211af5a9e049e66105d2e12669f207983c9a27f',\n",
       "   'title': 'Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.',\n",
       "   'abstract': \"BACKGROUND\\nPersistent patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. Prostaglandin synthetase inhibitors such as indomethacin promote PDA closure but also have potential side effects. The effect of the prophylactic use of indomethacin, where infants who may not have gone on to develop a symptomatic PDA would be exposed to indomethacin, warrants particular scrutiny.\\n\\n\\nOBJECTIVES\\nTo determine the effect of prophylactic indomethacin on mortality and morbidity in preterm infants.\\n\\n\\nSEARCH STRATEGY\\nThe standard search strategy of the Cochrane Neonatal Review Group was used. This included searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 5, 2010), MEDLINE, EMBASE and CINAHL (until April 2010), conference proceedings, and previous reviews.\\n\\n\\nSELECTION CRITERIA\\nRandomised or quasi-randomised controlled trials that compared prophylactic indomethacin versus placebo or no drug in preterm infants.\\n\\n\\nDATA COLLECTION AND ANALYSIS\\nThe standard methods of the Cochrane Neonatal Review Group were used, with separate evaluation of trial quality and data extraction by two review authors.\\n\\n\\nMAIN RESULTS\\nNineteen eligible trials in which 2872 infants participated were identified. Most participants were very low birth weight, but the largest single trial restricted participation to extremely low birth weight infants (N = 1202). The trials were generally of good quality.The incidence of symptomatic PDA [typical relative risk (RR) 0.44, 95% confidence interval (CI) 0.38 to 0.50] and PDA surgical ligation (typical RR 0.51, 95% CI 0.37,0.71) was significantly lower in treated infants. Prophylactic indomethacin also significantly reduced the incidence of severe intraventricular haemorrhage (typical RR 0.66, 95% CI 0.53 to 0.82). Meta-analyses found no evidence of an effect on mortality (typical RR 0.96, 95% CI 0.81 to 1.12) or on a composite of death or severe neurodevelopmental disability assessed at 18 to 36 months old (typical RR 1.02, 95% CI 0.90, 1.15).\\n\\n\\nAUTHORS' CONCLUSIONS\\nProphylactic indomethacin has short-term benefits for preterm infants including a reduction in the incidence of symptomatic PDA, PDA surgical ligation, and severe intraventricular haemorrhage. However, there is no evidence of effect on mortality or neurodevelopment.\",\n",
       "   'year': 2010,\n",
       "   'citationCount': 57},\n",
       "  {'paperId': '8655f0fe88af938fdd34571fb0d5c3210ac30607',\n",
       "   'title': 'Cochrane Review: Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants',\n",
       "   'abstract': \"Background \\nPatent ductus arteriosus (PDA) and intraventricular haemorrhage (IVH) are both associated with increased mortality and morbidity in preterm infants. Indomethacin has been used successfully to treat symptomatic PDA and may also prevent or limit IVH in the neonatal period. There are however potential unwanted side effects of indomethacin, in particular a potential for reduced organ perfusion that might outweigh any clinical benefits. The prophylactic use of indomethacin, where infants who may not have gone on to develop a symptomatic PDA or IVH would be exposed to indomethacin, warrants particular scrutiny. \\n \\nObjectives \\nThis review examines the effectiveness of prophylactic intravenous indomethacin in reducing the mortality and morbidity associated with PDA and IVH in preterm infants. \\n \\nSearch strategy \\nAn initial literature search was conducted in three computerised databases: MEDLINE; EMBASE; and the Oxford Database of Perinatal Trials in October 1994. The search was updated in February 1997 and October 2001. \\n \\nSelection criteria \\nStrict selection criteria were applied to clinical trials: the population had to be newborn preterm infants (less than 37 completed weeks gestation); the intervention had to be prophylactic intravenous indomethacin; the trial had to be randomised and controlled; and at least one of several prespecified outcomes had to be reported in the results. \\n \\nData collection and analysis \\nThe methodological quality of each study was assessed using explicit criteria. Data on relevant outcome measures were extracted and, where appropriate, the results of individual trials were combined using meta-analysis techniques to provide a pooled estimate of effect. \\n \\nMain results \\nNineteen eligible trials randomising 2872 infants were identified. \\n \\nThere is no evidence of difference in mortality at latest follow-up between infants receiving prophylactic indomethacin and controls, pooled relative risk (RR) = 0.96 [95% CI 0.81 to 1.12]. \\n \\nThere is no evidence to suggest prophylactic indomethacin is associated with any reduction in long-term neurosensory impairment, ie no significant difference in rates of cognitive delay, cerebral palsy, blindness or deafness. \\n \\nThe incidence of symptomatic patent ductus arteriosus is significantly reduced in treated infants, pooled RR = 0.44 [0.38 to 0.50] but there is no evidence that treatment affects respiratory outcomes. Prophylactic indomethacin reduces the need for surgical PDA ligation [RR = 0.51 (0.37,0.71)]. \\n \\nProphylactic indomethacin significantly reduces the incidence of Grade 3 and 4 intraventricular haemorrhage, pooled RR = 0.66 [0.53 to 0.82]. \\n \\nThere is no evidence of difference in rates of necrotising enterocolitis, excessive clinical bleeding or sepsis. Increased incidence of oliguria is seen with prophylactic indomethacin [RR = 1.90 (1.45,2.47] but this is not associated with major renal impairment. \\n \\nAuthors' conclusions \\nProphylactic treatment with indomethacin has a number of immediate benefits, in particular a reduction in symptomatic patent ductus arteriosus, the need for duct ligation and severe intraventricular haemorrhage. There is no evidence to suggest either benefit or harm in longer term outcomes including neurodevelopment. Depending on clinical circumstances and personal preferences, there may be a role for prophylactic indomethacin in some infants on some neonatal units. \\n \\nPlain Language Summary \\nProphylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants \\n \\nPatent ductus arteriosus (PDA) occurs when an artery near the heart and lungs, which should close off soon after birth, stays open. Babies born too early (preterm) with PDA are at increased risk of severe illness and death. Indomethacin has been given to very small babies within 24 hours of birth to help close a PDA, at the same time reducing the risk of bleeding into the head - intraventricular hemorrhage (IVH). The review found that giving indomethacin to preterm babies reduced their risk of both PDA and IVH. Indomethacin may also reduce blood flow in some organs including the brain but this does not seem to cause any serious lasting adverse effects. However, giving prophylactic indomethacin has no effect on the development of the babies in the longer term - development is neither better nor worse than the development of babies who have not received the treatment - suggesting its use may be limited to achieving short-term benefits only.\",\n",
       "   'year': 2010,\n",
       "   'citationCount': 0},\n",
       "  {'paperId': '6ad557026f847a61bc1d349089c2bff8e300537f',\n",
       "   'title': 'Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?',\n",
       "   'abstract': None,\n",
       "   'year': 2010,\n",
       "   'citationCount': 348},\n",
       "  {'paperId': '7d0f5a1c9c4b74bbd2a0c3d6ad7309d99077111c',\n",
       "   'title': \"SIBEN's First Clinical Consensus: Diagnostic and Therapeutic Approach to the Patent Ductus Arteriosus in Preterm Infants\",\n",
       "   'abstract': 'Objective To report the process and results of the first neonatal clinical consensus of the Ibero-American region. Design and methods Two recognized experts in the field (Clyman and Van Overmeire) and 45 neonatologists from 23 countries were invited for active participation and collaboration. We developed 46 questions of clinical-physiological relevance in all aspects of patent ductus arteriosus (PDA). Guidelines for consensus process, literature search and future preparation of educational material and authorship were developed, reviewed and agreed by all. Participants from different countries were distributed in groups, and assigned to interact and work together to answer 3-5 questions, reviewing all global literature and local factors. Answers and summaries were received, collated and reviewed by 2 coordinators and the 2 experts. Participants and experts met in Granada, Spain for 4.5 h (lectures by experts, presentations by groups, discussion, all literature available). Results 31 neonatologists from 16 countries agreed to participate. Presentations by each group and general discussion were used to develop a consensus regarding: general management, availability of drugs (indomethacin vs. ibuprofen), costs, indications for echo/surgery, etc. Many steps were learnt by all present in a collaborative forum. Conclusions This first consensus group of Ibero-American neonatologists SIBEN led to active and collaborative participation of neonatologists of 16 countries, improved education of all participants and ended with consensus development on clinical approaches to PDA. Furthermore, it provides recommendations for clinical care reached by consensus. Additionally, it will serve as a useful foundation for future SIBEN Consensus on other topics and it could become valuable as a model to decrease disparity in care and improve outcomes in this and other regions.',\n",
       "   'year': 2008,\n",
       "   'citationCount': 15},\n",
       "  {'paperId': '1328fdde4bc2df28c20b38cc3b9b84c39cf0a193',\n",
       "   'title': 'Primer consenso clínico de SIBEN: enfoque diagnóstico y terapéutico del ductus arterioso permeable en recién nacidos pretérmino',\n",
       "   'abstract': 'Objetivo Informar acerca del proceso y de los resultados del primer consenso clinico neonatal de la region iberoamericana. Diseno y metodos Dos expertos reconocidos en el area (los Dres. Clyman y Van Overmeire) y 45 neonatologos de 23 paises fueron invitados a participar y a colaborar. Se desarrollaron 46 preguntas de importancia clinico-fisiologica sobre la totalidad de los aspectos del ductus arterioso permeable (DAP). Las pautas para el proceso del consenso, la busqueda de la bibliografia y la futura preparacion de material educativo y autoria fueron descritas, revisadas y acordadas por todos los participantes. Los expertos de diferentes paises fueron distribuidos en grupos, y asignados para interactuar y trabajar conjuntamente para responder a las 3-5 preguntas, revisando la totalidad de la bibliografia globalmente y los factores locales. Las respuestas y los resumenes fueron recibidos, cotejados y revisados por 2 coordinadores y los 2 expertos. Los participantes y los expertos se reunieron en Granada, Espana, durante 4,5 h (con conferencias de expertos, presentaciones por grupos y discusion de toda la bibliografia de la que se disponia). Resultados Participaron 31 neonatologos de 16 paises. Las presentaciones de cada grupo y la discusion general se utilizaron para desarrollar un consenso en el que se consideraron: tratamiento general, disponibilidad de farmacos (indometacina frente a ibuprofeno), costes, indicaciones para eco/cirugia, etc. En este foro de cooperacion, los participantes aprendieron numerosos aspectos del tratamiento de esta entidad. Conclusiones Este primer grupo de consenso de neonatologos iberoamericanos de SIBEN llevo a la participacion activa y cooperativa de neonatolologos de 16 paises, mejoro la educacion de todos los participantes y finalizo desarrollando un consenso sobre los enfoques clinicos del DAP. Ademas, indica recomendaciones para el cuidado clinico a las que se ha llegado mediante consenso. Asimismo, servira como una base util para futuros consensos de SIBEN en otros temas y podria llegar a ser un valioso modelo para disminuir la disparidad en el cuidado y mejorar los resultados en esta y en otras regiones.',\n",
       "   'year': 2008,\n",
       "   'citationCount': 47},\n",
       "  {'paperId': '470ed9f057df6f9842f9254a283ea091014ab88d',\n",
       "   'title': 'Patent Ductus Arteriosus and Respiratory Outcome in Premature Infants',\n",
       "   'abstract': 'A persistent ductus arteriosus is a common event in preterm infants. The systemic-to-pulmonary shunting that occurs as the pulmonary vascular resistance decreases after birth can have significant cardiovascular and respiratory consequences. Acute pulmonary effects include pulmonary edema and hemorrhage, worsened lung mechanics and deterioration in gas exchange with hypoxemia and hypercapnia. The increased pulmonary blood flow can also produce damage to the capillary endothelium and trigger an inflammatory cascade. This, plus the need for longer and more aggressive mechanical ventilation, can explain the association between patent ductus arteriosus and an increased risk for bronchopulmonary dysplasia in extremely premature infants.',\n",
       "   'year': 2005,\n",
       "   'citationCount': 114},\n",
       "  {'paperId': 'bf5d9482774219728cfc6ebb1dd851c4eb3784e8',\n",
       "   'title': 'Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis',\n",
       "   'abstract': 'Background: Rates of long term morbidity remain unacceptably high in infants surviving after preterm birth. Prophylactic indomethacin has been shown to effectively reduce the rate of intraventricular haemorrhage in this group but there is the potential for unwanted side effects because of reduced organ perfusion. Objective: To examine the effect of prophylactic indomethacin on mortality and short and long term morbidity of preterm infants. Data sources: Medline (1966–2002), the Cochrane Controlled Trials Register and abstracts of the Society for Pediatric Research and the European Society for Pediatric Research were searched independently by both authors. Review methods: Trials were included if they used a randomised design, enrolled preterm infants given intravenous indomethacin within 24 hours of birth, and reported any of the prespecified outcome measures. Each author extracted data and assessed trial quality independently, according to the methods of the Cochrane Collaboration. Data were combined in a meta-analysis where appropriate. Results: Nineteen trials fulfilling the inclusion criteria were identified, of which four reported long term outcomes. Short term benefits of indomethacin were identified, including a reduction in the rate of severe intraventricular haemorrhage (relative risk (RR) 0.66 (95% confidence interval (CI) 0.53 to 0.82)) and the need for surgical ligation of a patent ductus arteriosus (RR 0.51 (95% CI 0.37 to 0.71)). No evidence of short term gastrointestinal or renal adverse effects was detected. There was no significant difference between indomethacin and control groups with respect to the important long term outcome of death or severe neurosensory impairment (RR 1.02 (95% CI 0.90 to 1.15)). Conclusions: Prophylactic indomethacin has a number of short term benefits for the preterm infant but there is no evidence to suggest that it results in an improvement in the rate of survival free of disability.',\n",
       "   'year': 2003,\n",
       "   'citationCount': 141},\n",
       "  {'paperId': '10e9e2382ec750d7e126e20dda1af87d9cd19665',\n",
       "   'title': 'The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials.',\n",
       "   'abstract': 'Patent ductus arteriosus (PDA) is a common problem in very preterm infants. It results in a significant left-to-right shunt and an increase in left ventricular output. Pulmonary compliance can be reduced. Systemic effects result from the diastolic steal and retrograde diastolic blood flow. Randomized controlled trials of PDA closure fall into three groups: (i) prophylactic treatment in the first 24 h, (ii) pre-symptomatic treatment on ultrasound evidence of a PDA or the first clinical signs and (iii) treatment when it becomes haemodynamically significant. Prophylactic treatment with indomethacin reduces the incidence of intraventricular haemorrhage. All the trials have a decreased need to treat a subsequent PDA in the treatment group. There are no other improvements in outcome, without any change in mortality, bronchopulmonary dysplasia, necrotizing enterocolitis or retinopathy of prematurity. Clinical decisions on the treatment of the ductus should be individualized and based on the gestation of the baby, the respiratory condition and the size of the ductal shunt.',\n",
       "   'year': 2001,\n",
       "   'citationCount': 161},\n",
       "  {'paperId': '4c45c6fc25d450a4f332167f1ecbe0acc8d185c5',\n",
       "   'title': 'Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants.',\n",
       "   'abstract': 'A previous study found that early intravenous indomethacin administration prolonged respiratory support in very low birth weight infants. We have, therefore, designed a randomized, double blind controlled study to evaluate the oxygenation, and surfactant requirements in preterm low birth weight infants receiving early indomethacin administration. Premature neonates who received surfactant therapy and on mechanical ventilation were prospectively randomized to receive either placebo or indomethacin (0.2 mg/kg intravenously at 12 postnatal hours and every 24 h for two more doses). Oxygenation was assessed by FiO2 required and arterial/alveolar oxygen (a/A O2) ratio during the first 48 h of life. The doses of surfactant were compared between the two groups. Twenty-seven infants (n = 14 of early indomethacin and n = 13 of placebo group) fulfilled inclusion criteria. At admission to the study, there were no differences in the birth weight, gestational age, sex, Apgar scores, a/A O2 ratio, and FiO2. The control group exhibited a significant improvement in oxygenation (FiO2 requirement and a/A O2 compared with the early indomethacin group at 24 (P = 0.026 and 0.02, respectively) and 48 h of life (P = 0.037 and 0.026, respectively). The requirement of surfactant was significantly larger in the early indomethacin group (P = 0.029). Early indomethacin administration increases oxygen and surfactant requirement.',\n",
       "   'year': 1997,\n",
       "   'citationCount': 23},\n",
       "  {'paperId': '137b089e84b379231f894e70c960ba182e6eb169',\n",
       "   'title': 'Prolonged low‐dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants',\n",
       "   'abstract': 'To determine the efficacy and side‐effects of prolonged low‐dose indomethacin therapy in very low birthweight (VLBW; <1500 g) infants with a haemodynamically significant patent ductus arteriosus (hsPDA).',\n",
       "   'year': 1997,\n",
       "   'citationCount': 24},\n",
       "  {'paperId': 'f9c6551e288cc72e2ba5dd561548eb006a28087f',\n",
       "   'title': 'Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.',\n",
       "   'abstract': None,\n",
       "   'year': 1996,\n",
       "   'citationCount': 185},\n",
       "  {'paperId': 'e66bdc8f60ad00e2b7b0d03f140ac20e25329b48',\n",
       "   'title': 'Prophylactic indomethacin: systematic review and meta-analysis.',\n",
       "   'abstract': 'AIMS: To examine the effectiveness of prophylactic intravenous indomethacin in reducing the mortality and morbidity associated with patent ductus arteriosus and intraventricular haemorrhage in infants weighing less than 1750 g at birth. METHODS: A literature search from 1980 onwards was made of three databases: Medline; Embase; and the Oxford Database of Perinatal Trials. Using strict criteria applied to randomised controlled trials only, two observers independently selected 14 studies for inclusion in the review. The methodological quality of each study was assessed independently by two observers using explicit criteria. Data on relevant outcome measures were extracted on two separate occasions. Where appropriate, the results of individual trials were combined using meta-analysis techniques to provide a pooled estimate of effect. RESULTS: There is a trend towards reduced neonatal mortality in infants receiving prophylactic indomethacin, pooled estimate of risk difference -0.025 (95% confidence interval (CI) -0.061, 0.010). The incidence of symptomatic patent ductus arteriosus is significantly reduced in treated infants, pooled estimate of risk difference -0.217 (95% CI -0.275, -0.160), but there is no evidence that treatment affects respiratory outcomes. Prophylactic indomethacin significantly reduces the incidence of grades 3 and 4 intraventricular haemorrhage in treated infants, pooled estimate of risk difference -0.039 (95% CI -0.066, -0.011). However, there is no sound evidence assessing the long term effect of prophylaxis on neurodevelopmental outcome. Although there is a trend in treated infants towards an increased incidence of necrotising enterocolitis, pooled estimate of risk difference 0.015 (95% CI -0.002, 0.033), and some evidence that treatment may transiently impair renal function, there is no evidence that haemostasis is disturbed. CONCLUSION: Prophylactic treatment with indomethacin has several immediate benefits. However, more data are needed on the incidence of possible adverse effects and neurodevelopmental outcomes before routine use of this therapy can be recommended.',\n",
       "   'year': 1996,\n",
       "   'citationCount': 65},\n",
       "  {'paperId': '278877c1ecf36d64c3f6c3348d79d0e7e72a17cb',\n",
       "   'title': 'Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation.',\n",
       "   'abstract': None,\n",
       "   'year': 1995,\n",
       "   'citationCount': 263},\n",
       "  {'paperId': '307a10257316b85fee4075ebd4d8a56c8a82e8b4',\n",
       "   'title': 'Prevention of intraventricular hemorrhage in preterm infants.',\n",
       "   'abstract': None,\n",
       "   'year': 1995,\n",
       "   'citationCount': 79},\n",
       "  {'paperId': 'e6adbc77b59a3caf102a93c1946a142a238b5d5b',\n",
       "   'title': 'Patent ductus arteriosus in the preterm infant.',\n",
       "   'abstract': None,\n",
       "   'year': 1993,\n",
       "   'citationCount': 13},\n",
       "  {'paperId': 'be415ea01e33e4c72ecc026e5f078c47b3236751',\n",
       "   'title': 'Patent ductus arteriosus: how important to which babies?',\n",
       "   'abstract': None,\n",
       "   'year': 1992,\n",
       "   'citationCount': 28},\n",
       "  {'paperId': '9e926fc2bdb33c3ab00eee2c99c0c6ba581e4f3f',\n",
       "   'title': 'Intravenous Indomethacin therapy in preterm neonates with patent ductus arteriosus',\n",
       "   'abstract': 'This study examined the response of the patent ductus arteriosus (PDA) to intravenous Indomethacin using serial two dimensional and Doppler echocardiography and documented the complications associated with therapy. Thirty‐six preterm neonates who were oxygen and ventilator dependent were studied when they were aged 3‐7 days. The PDA initially closed in 22 (61%) and constricted in seven (19%) of the infants. It was non‐responsive in five (14%) and the treatment was stopped because of complications in two (6%). Only three (43%) of seven neonates given a second course had PDA closure. In the 25 instances where there was PDA closure following Indomethacin, re‐opening was documented echocardiographically on three (12%) occasions. Overall, Indomethacin therapy was successful in 29 (81%) neonates, PDA ligation was required in four (11%) and three died from unrelated causes. Three (8%) neonates developed major complications: multiple gastric perforations in the first, focal ileal perforation in the second, and necrotizing enterocolitis in the third. Treatment failure. PDA ligation and major complications occurred exclusively in neonates <28 weeks gestation. In view of the relatively low efficacy and high major complication rate in these extremely preterm infants, a randomized clinical trial needs to be conducted using two dimensional and Doppler echocardiography to allow accurate assessment of the PDA response to intravenous Indomethacin.',\n",
       "   'year': 1991,\n",
       "   'citationCount': 32},\n",
       "  {'paperId': '7218452865dee9314dddc0effe4e0188a3e4957d',\n",
       "   'title': 'Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity.',\n",
       "   'abstract': 'A total of 121 infants who required indomethacin for persistent ductus arteriosus in Liverpool and Cambridge over a four year period were randomised to receive either 0.1 mg/kg daily for six days or 0.2 mg/kg every 12 hours for three doses. The groups were of similar birth weight and gestational and postnatal age, though those treated with a low dose were by chance receiving a higher percentage of oxygen at the start of treatment and there were more deaths from bronchopulmonary dysplasia in this group. Of 59 infants treated with the prolonged course 53 (90%) responded initially to indomethacin compared with 48 of 62 (77%) treated conventionally--a difference of 13% (95% confidence interval for the difference 0 to 26%). Of the 53 responders 11 (21%) relapsed after low dose indomethacin, whereas after the shorter course 19 of 48 (40%) relapsed. This difference was significant (95% confidence intervals 3 to 37%). Side effects, mainly gastrointestinal haemorrhage, were similar in both groups. Significantly fewer infants experienced a rise in serum creatinine or urea concentration after treatment with low dose indomethacin. A prolonged low dose course of indomethacin offers advantages over conventional treatment.',\n",
       "   'year': 1991,\n",
       "   'citationCount': 65},\n",
       "  {'paperId': 'fd602e4dc2e63a2af10a21bf113a19c0996c13bc',\n",
       "   'title': 'Persistent Patent Ductus Arteriosus',\n",
       "   'abstract': \"Two observations about the ductus arteriosus are established: most normally developed infants will have a patent ductus arteriosus (PDA) at the time of delivery, and most fullterm infants will have anatomic obliteration of the ductus lumen by 3–6 months of age. Studies designed to determine how a PDA contributes to an infant's morbidity or when a PDA becomes a persistently patent ductus arteriosus have been hampered by the lack of consistent diagnostic criteria for defining the condition. Ellison et al. (22) attempted to evaluate several commonly used criteria for diagnosing a large leftto-right shunt through the ductus arteriosus by noting the occurrence of each sign both before and 36–48 hours after surgical ligation. No single criterion sufficed as an indicator of PDA. Certain signs, such as continuous murmur or hyperactive left ventricular impulse, were specific for a PDA, but lacked sensitivity; conversely, M-mode echocardiography and ventilatory support criteria were very sensitive but lacked specificity.\",\n",
       "   'year': 1991,\n",
       "   'citationCount': 1},\n",
       "  {'paperId': 'e71a060319878dee59dfad26c9e719fffbfd0de9',\n",
       "   'title': 'Chapter 8 – Patent Ductus Arteriosus and the Lung: Acute Effects and Long-Term Consequences',\n",
       "   'abstract': None,\n",
       "   'year': 2012,\n",
       "   'citationCount': 0},\n",
       "  {'paperId': '10d0028f9bd07ad9380361fa06f2cfb909eea7b9',\n",
       "   'title': 'Chapter 9 – The Very Low Birth Weight Neonate with a Hemodynamically Significant Ductus Arteriosus during the First Postnatal Week',\n",
       "   'abstract': None,\n",
       "   'year': 2008,\n",
       "   'citationCount': 6},\n",
       "  {'paperId': 'e0de4fe52f6177ab1ec34983f2eecccea49648da',\n",
       "   'title': 'Indometacina intravenosa en la prevención de la hemorragia intraventricular en recién nacidos con peso menor o igual a 1,750 g, sometidos a ventilación asistida',\n",
       "   'abstract': 'Introduccion: Los recien nacidos prematuros con persistencia de conducto arterioso tienen un riesgo aumentado de presentar hemorragia intraventricular. El objetivo del trabajo fue comprobar si el uso de indometacina intravenosa en recien nacidos, con peso menor o igual a 1,750 gramos, previene en forma profilactica la aparicion de hemorragia intraventricular. Material y metodos: Se seleccionaron a recien nacidos que fueron sometidos a ventilacion mecanica, que no presentaron alteracion hemodinamica o hematologica, y que no presentaron malformaciones mayores. Se les administro tres dosis de indometacina 0.20.1-0.1 mg, cada 12 horas; se realizo ultrasonografia transfontanelar para verificar la presencia o no de hemorragia intraventricular. Para fines de comparacion se utilizo un control historico sin indometacina. Resultados: Se encontro una disminucion del riesgo para hemorragia para los pacientes a los que se les aplico indometacina (RM = 0.25; IC 95% 0.13-0.49; p < 0.001). Se encontro una disminucion del riesgo por grados de hemorragia, para el grado II (RM = 0.13; IC 95% 0.04 – 0.39; p < 0.01) y grado III (RM = .09; IC 0.01 0.68 95%; p < 0.0005). Conclusiones: De acuerdo con lo descrito por la literatura, se confirma un efecto protector del uso de la indometacina profilactica para recien nacidos con peso menor o igual a 1,750 gramos que recibieron ventilacion asistida.',\n",
       "   'year': 2001,\n",
       "   'citationCount': 0},\n",
       "  {'paperId': '8f33a7ceb96f673161da7c1c67f2a74df874aa6e',\n",
       "   'title': 'Comparative Tolerability of Pharmacological Treatments for Patent Ductus Arteriosus',\n",
       "   'abstract': None,\n",
       "   'year': 2001,\n",
       "   'citationCount': 34},\n",
       "  {'paperId': '57da44b511c593a5253540bea0fc80fa7f912d8f',\n",
       "   'title': 'Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.',\n",
       "   'abstract': \"BACKGROUND\\nThis section is under preparation and will be included in the next issue.\\n\\n\\nOBJECTIVES\\nIndomethacin is used to treat symptomatic patent ductus arteriosus and may prevent or limit intraventricular haemorrhage in the neonatal period. This review examines the effectiveness of prophylactic intravenous indomethacin in reducing the mortality and morbidity associated with these conditions in infants weighing less than 1750 grams at birth.\\n\\n\\nSEARCH STRATEGY\\nA literature search from January 1980 to October 1994 was made in three computerised data bases: Medline; Embase; and the Oxford Database of Perinatal Trials. The search was updated in February 1997.\\n\\n\\nSELECTION CRITERIA\\nStrict selection criteria were applied to clinical trials: the population had to be newborn infants of birth weight < 1751 grams; the intervention had to be prophylactic intravenous indomethacin; the trial had to be randomised and controlled; and at least one of several prespecified outcomes had to be reported in the results.\\n\\n\\nDATA COLLECTION AND ANALYSIS\\nThe methodological quality of each study was assessed using explicit criteria. Data on relevant outcome measures were extracted on two separate occasions and, where appropriate, the results of individual trials were combined using meta-analysis techniques to provide a pooled estimate of effect.\\n\\n\\nMAIN RESULTS\\nThere is a trend towards reduced neonatal mortality in infants receiving prophylactic indomethacin, pooled relative risk (RR) = 0. 85 [95% CI 0.66 to 1.09]. The incidence of symptomatic patent ductus arteriosus is significantly reduced in treated infants, pooled RR = 0.35 [0.26 to 0.47] but there is no evidence that treatment affects respiratory outcomes. Prophylactic indomethacin significantly reduces the incidence of Grade 3 and 4 intraventricular haemorrhage in treated infants, pooled RR = 0.60 [0.43 to 0.83]. There is no evidence to suggest prophylactic indomethacin is associated with any long term adverse effect although there is a trend in treated infants towards an increased incidence of necrotizing enterocolitis, and some evidence that treatment may transiently impair renal function. There is no evidence that haemostasis is disturbed.\\n\\n\\nREVIEWER'S CONCLUSIONS\\nProphylactic treatment with indomethacin has a number of immediate benefits, in particular a reduction in symptomatic patent ductus arteriosus and severe intraventricular haemorrhage. There is no evidence at present of long-term harm. Further trials are needed to assess more precisely the effects, both beneficial and harmful, on short and long-term outcomes.\",\n",
       "   'year': 2000,\n",
       "   'citationCount': 205},\n",
       "  {'paperId': '9d0027dd69312f87c861fdadab0be69d022e28c0',\n",
       "   'title': '“Silent” patent ductus arteriosus and bronchopulmonary dysplasia in low birth weight infants',\n",
       "   'abstract': 'We conducted a clinical study on the antecedents of bronchopulmonary dysplasia (BPD) in 290 premature RDS infants with < or = 1.75 kg birth weight (BW). They were enrolled in a prospective trial of indomethacin treatment for \"silent\" patent ductus arteriosus (PDA), screened by 2-D echocardiographic and pulsed Doppler evaluation on the third day of life. The trial took place at the NICU of the Pediatric Department of Padua University between January 1987 and December 1991. Out of 290 infants screened, 96 had evidence of \"silent\" PDA (33%) and 77 responded to indomethacin treatment (80%). Comprehensively 79 (27%) developed BPD, and from these the incidence of BPD was statistically increased in infants with \"silent\" PDA, 47 out of 96 (49 +/- 9%), with respect to 32 out of 194 (16 +/- 3%) preterm infants without PDA. Statistical analysis showed that in preterm infants with \"silent\" PDA the development of BPD was correlated at 99% C.L. to their low BWs (mean BW = 1.13 kg): in fact the mean and the mode of BW distributions were statistically lower in the presence of BPD, 1.03 kg versus 1.24 kg, and 0.88 kg versus 1.65 kg respectively. Moreover, the preterm infants with \"silent\" PDA unresponsive to the first course of indomethacin and/or submitted later to surgical closure, presented a statistically lower BW with respect to the early responders, 1.06 kg versus 1.18 kg, and at the same time a statistically higher incidence of BPD (63 +/- 20% versus 43 +/- 9%). From these data we conclude that, although \"silent\", PDA increase per se the incidence of BPD, even if benefits from an early induced closure. Furthermore, a lower BW of infants affected by \"silent\" PDA represents a contributing factor to the development of BPD.',\n",
       "   'year': 1995,\n",
       "   'citationCount': 10},\n",
       "  {'paperId': '31de3d535c5e7025a037346004a8d93c2d56ce50',\n",
       "   'title': 'Pathogenesis and prevention of neonatal chronic lung disease: Recent developments',\n",
       "   'abstract': \"The improved survival of very low birthweight infants who require prolonged mechanical ventilation has resulted in an increased number of infants who are susceptible to developing the chronic lung disease bronchopulmonary dysplasia (BPD). Although no major breakthroughs in the prevention of this problem have occurred since its description in the 1960s, new information on the pathogenesis of neonatal chronic lung disease (CLD) has led to a reduction of the severity of lung damage and improved long-term outcome for these patients. Follow-up studies have shown that the majority of infants who are still oxygen-dependent at 28 days of age have relatively normal pulmonary function 2 years later.'-3 The following are some of the new developments that have contributed to the better prognosis of these infants.\",\n",
       "   'year': 1990,\n",
       "   'citationCount': 28}]}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "get_paper_by_id('PMID:3321891')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "get_paper_data('43edaf3dfe704bea74ebc68c75682cae41a58495')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "get_citings_by_id('PMID:3998921')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_linear_chain(data, chain=[]):\n",
    "    # If the current level has a paper, add it to the chain\n",
    "    if \"paper\" in data:\n",
    "        chain.append({\n",
    "            \"paperId\": data[\"paper\"][\"paperId\"],\n",
    "            \"title\": data[\"paper\"][\"title\"],\n",
    "            \"abstract\": data[\"paper\"][\"abstract\"],\n",
    "            \"year\": data[\"paper\"][\"year\"],\n",
    "            \"citation_count\": data[\"paper\"][\"citation_count\"],\n",
    "            \"relevance\": data[\"paper\"][\"relevance\"],\n",
    "            \"explanation\": data[\"paper\"][\"explanation\"]\n",
    "        })\n",
    "    \n",
    "    # If there's a chain at this level, traverse it\n",
    "    if \"chain\" in data and isinstance(data[\"chain\"], dict):\n",
    "        for year, nested_chain in data[\"chain\"].items():\n",
    "            for nested_data in nested_chain:\n",
    "                extract_linear_chain(nested_data, chain)\n",
    "    \n",
    "    return chain\n",
    "\n",
    "import json\n",
    "# read the json data\n",
    "with open(\"../temporal_chains_llama.json\") as f:\n",
    "    json_data = json.load(f)\n",
    "linear_chain = []\n",
    "for year, entries in json_data.items():\n",
    "    for entry in entries:\n",
    "        linear_chain = extract_linear_chain(entry, chain=linear_chain)\n",
    "\n",
    "import pandas as pd\n",
    "df = pd.DataFrame(linear_chain)\n",
    "df = df.sort_values(by=[\"year\"], ascending=[True])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>paperId</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>year</th>\n",
       "      <th>citation_count</th>\n",
       "      <th>relevance</th>\n",
       "      <th>explanation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>c255df3fb3fba0205479c2d4632897f91876c9e1</td>\n",
       "      <td>Impact of bronchopulmonary dysplasia, brain in...</td>\n",
       "      <td>CONTEXT\\nDespite more than 2 decades of outcom...</td>\n",
       "      <td>2003</td>\n",
       "      <td>540</td>\n",
       "      <td>2</td>\n",
       "      <td>This paper is directly related to the source p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>50f69c376ccdde9a7ddcaa712ccac07105b1f5d0</td>\n",
       "      <td>Chronic Conditions, Functional Limitations, an...</td>\n",
       "      <td>CONTEXT\\nInformation on the school-age functio...</td>\n",
       "      <td>2005</td>\n",
       "      <td>1238</td>\n",
       "      <td>1</td>\n",
       "      <td>This paper examines the chronic conditions, fu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>aac266ca577d5b8148097608db85c90fe85fbdc3</td>\n",
       "      <td>Improved Neurodevelopmental Outcomes for Extre...</td>\n",
       "      <td>BACKGROUND. Neurodevelopmental impairment of e...</td>\n",
       "      <td>2007</td>\n",
       "      <td>401</td>\n",
       "      <td>2</td>\n",
       "      <td>This paper is partially dependent on the findi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>690ddc2eb03d864b19e286d612cc90077938ec1a</td>\n",
       "      <td>Long-Term Medical and Social Consequences of P...</td>\n",
       "      <td>As the care of premature infants has improved ...</td>\n",
       "      <td>2009</td>\n",
       "      <td>1201</td>\n",
       "      <td>1</td>\n",
       "      <td>The paper examines the long-term consequences ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>29e31ec682a660dfc01b870100552a27fad4001a</td>\n",
       "      <td>Preterm Birth and Childhood Psychiatric Disorders</td>\n",
       "      <td>Epidemiologic studies have, for many years, id...</td>\n",
       "      <td>2011</td>\n",
       "      <td>501</td>\n",
       "      <td>2</td>\n",
       "      <td>This paper reviews the relationship between pr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>a6a0e355146104218ada59d47fd779c718dee88a</td>\n",
       "      <td>Psychiatric outcomes at age seven for very pre...</td>\n",
       "      <td>BACKGROUND\\n  Uncertainty remains about the ra...</td>\n",
       "      <td>2013</td>\n",
       "      <td>203</td>\n",
       "      <td>2</td>\n",
       "      <td>The key hypothesis in this paper is at least p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>99e8f2b0a6827911fe20bfa7f964fe3a689902e0</td>\n",
       "      <td>Structural Brain Connectivity in School-Age Pr...</td>\n",
       "      <td>Extreme prematurity and pregnancy conditions l...</td>\n",
       "      <td>2015</td>\n",
       "      <td>185</td>\n",
       "      <td>2</td>\n",
       "      <td>This paper examines the structural brain conne...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>2a8add452e58105c515f682edc6b94077739e38e</td>\n",
       "      <td>Reinforcement of the Brain's Rich-Club Archite...</td>\n",
       "      <td>The second half of pregnancy is a crucial peri...</td>\n",
       "      <td>2016</td>\n",
       "      <td>79</td>\n",
       "      <td>2</td>\n",
       "      <td>This paper examines the effects of very preter...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>f12a0bbb1b2fd2dae7803d0b15d197a358379fd8</td>\n",
       "      <td>Annual Research Review: Not just a small adult...</td>\n",
       "      <td>Background There has been a recent proliferati...</td>\n",
       "      <td>2017</td>\n",
       "      <td>74</td>\n",
       "      <td>1</td>\n",
       "      <td>This paper reviews neuroimaging studies invest...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>334401b886a0f390f655f0659af290f2267dd02c</td>\n",
       "      <td>The Protracted Maturation of Associative Layer...</td>\n",
       "      <td>The human specific cognitive shift starts arou...</td>\n",
       "      <td>2019</td>\n",
       "      <td>43</td>\n",
       "      <td>2</td>\n",
       "      <td>This paper is partially dependent on the findi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>56feaaa7d74755ccf6564c4aa196103c19ea58d3</td>\n",
       "      <td>Verbal and General IQ Associate with Supragran...</td>\n",
       "      <td>Abstract The left temporal lobe is an integral...</td>\n",
       "      <td>2021</td>\n",
       "      <td>17</td>\n",
       "      <td>1</td>\n",
       "      <td>This paper examines the relationship between c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>30f6b912decaedd2d4a06c21ae2d881e83ac398b</td>\n",
       "      <td>Strong and reliable synaptic communication bet...</td>\n",
       "      <td>Abstract Synaptic transmission constitutes the...</td>\n",
       "      <td>2022</td>\n",
       "      <td>27</td>\n",
       "      <td>1</td>\n",
       "      <td>This paper investigates synaptic transmission ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>582bf754d9f50dc3f29b0b5122e497e96ecd67de</td>\n",
       "      <td>Directed and acyclic synaptic connectivity in ...</td>\n",
       "      <td>The computational capabilities of neuronal net...</td>\n",
       "      <td>2024</td>\n",
       "      <td>7</td>\n",
       "      <td>2</td>\n",
       "      <td>The paper studies the network properties withi...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     paperId  \\\n",
       "0   c255df3fb3fba0205479c2d4632897f91876c9e1   \n",
       "1   50f69c376ccdde9a7ddcaa712ccac07105b1f5d0   \n",
       "2   aac266ca577d5b8148097608db85c90fe85fbdc3   \n",
       "3   690ddc2eb03d864b19e286d612cc90077938ec1a   \n",
       "4   29e31ec682a660dfc01b870100552a27fad4001a   \n",
       "5   a6a0e355146104218ada59d47fd779c718dee88a   \n",
       "6   99e8f2b0a6827911fe20bfa7f964fe3a689902e0   \n",
       "7   2a8add452e58105c515f682edc6b94077739e38e   \n",
       "8   f12a0bbb1b2fd2dae7803d0b15d197a358379fd8   \n",
       "9   334401b886a0f390f655f0659af290f2267dd02c   \n",
       "10  56feaaa7d74755ccf6564c4aa196103c19ea58d3   \n",
       "11  30f6b912decaedd2d4a06c21ae2d881e83ac398b   \n",
       "12  582bf754d9f50dc3f29b0b5122e497e96ecd67de   \n",
       "\n",
       "                                                title  \\\n",
       "0   Impact of bronchopulmonary dysplasia, brain in...   \n",
       "1   Chronic Conditions, Functional Limitations, an...   \n",
       "2   Improved Neurodevelopmental Outcomes for Extre...   \n",
       "3   Long-Term Medical and Social Consequences of P...   \n",
       "4   Preterm Birth and Childhood Psychiatric Disorders   \n",
       "5   Psychiatric outcomes at age seven for very pre...   \n",
       "6   Structural Brain Connectivity in School-Age Pr...   \n",
       "7   Reinforcement of the Brain's Rich-Club Archite...   \n",
       "8   Annual Research Review: Not just a small adult...   \n",
       "9   The Protracted Maturation of Associative Layer...   \n",
       "10  Verbal and General IQ Associate with Supragran...   \n",
       "11  Strong and reliable synaptic communication bet...   \n",
       "12  Directed and acyclic synaptic connectivity in ...   \n",
       "\n",
       "                                             abstract  year  citation_count  \\\n",
       "0   CONTEXT\\nDespite more than 2 decades of outcom...  2003             540   \n",
       "1   CONTEXT\\nInformation on the school-age functio...  2005            1238   \n",
       "2   BACKGROUND. Neurodevelopmental impairment of e...  2007             401   \n",
       "3   As the care of premature infants has improved ...  2009            1201   \n",
       "4   Epidemiologic studies have, for many years, id...  2011             501   \n",
       "5   BACKGROUND\\n  Uncertainty remains about the ra...  2013             203   \n",
       "6   Extreme prematurity and pregnancy conditions l...  2015             185   \n",
       "7   The second half of pregnancy is a crucial peri...  2016              79   \n",
       "8   Background There has been a recent proliferati...  2017              74   \n",
       "9   The human specific cognitive shift starts arou...  2019              43   \n",
       "10  Abstract The left temporal lobe is an integral...  2021              17   \n",
       "11  Abstract Synaptic transmission constitutes the...  2022              27   \n",
       "12  The computational capabilities of neuronal net...  2024               7   \n",
       "\n",
       "    relevance                                        explanation  \n",
       "0           2  This paper is directly related to the source p...  \n",
       "1           1  This paper examines the chronic conditions, fu...  \n",
       "2           2  This paper is partially dependent on the findi...  \n",
       "3           1  The paper examines the long-term consequences ...  \n",
       "4           2  This paper reviews the relationship between pr...  \n",
       "5           2  The key hypothesis in this paper is at least p...  \n",
       "6           2  This paper examines the structural brain conne...  \n",
       "7           2  This paper examines the effects of very preter...  \n",
       "8           1  This paper reviews neuroimaging studies invest...  \n",
       "9           2  This paper is partially dependent on the findi...  \n",
       "10          1  This paper examines the relationship between c...  \n",
       "11          1  This paper investigates synaptic transmission ...  \n",
       "12          2  The paper studies the network properties withi...  "
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "json_output = df.to_json(orient=\"records\", indent=4)\n",
    "\n",
    "with open(\"temporal_chains_llama_v1.json\", \"w\") as file:\n",
    "    file.write(json_output)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                                  title   Seed  Score\n",
      "0     Repeated Exercise Induces Release of Soluble P...     42      2\n",
      "1     Should Claudicants Receive Angioplasty or Exer...     42      1\n",
      "2     Intermittent claudication should not be treate...     42      0\n",
      "3     Exercise and nursing therapy for patients with...     42      0\n",
      "4     Treatment of intermittent claudication with ph...     42      0\n",
      "...                                                 ...    ...    ...\n",
      "1295  Assessment and management of acute pain in hig...  39517      0\n",
      "1296  DAILY COST PREDICTION MODEL IN NEONATAL INTENS...  39517      0\n",
      "1297  Impact of bronchopulmonary dysplasia, brain in...  39517      1\n",
      "1298  Indomethacin for asymptomatic patent ductus ar...  39517      1\n",
      "1299  Management of Patent Ductus Arteriosus in Very...  39517      1\n",
      "\n",
      "[1300 rows x 3 columns]\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# Load data\n",
    "file_path = './llama_scores.csv'\n",
    "data = pd.read_csv(file_path)\n",
    "\n",
    "# Melt the DataFrame\n",
    "melted_data = pd.melt(\n",
    "    data,\n",
    "    id_vars=[data.columns[0]],  # First column as identifier (titles)\n",
    "    var_name='Seed',            # Name for the variable column (seeds)\n",
    "    value_name='Score'          # Name for the value column (scores)\n",
    ")\n",
    "\n",
    "# Display the melted DataFrame\n",
    "print(melted_data)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                       Metric     Value\n",
      "0               Mean Variance  0.243544\n",
      "1             Median Variance  0.239474\n",
      "2                Min Variance       0.0\n",
      "3                Max Variance  0.660526\n",
      "4  Proportion of Low Variance    25.00%\n",
      "5         Low Variance Points        16\n",
      "6        High Variance Points         6\n"
     ]
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "# Compute variance for each data point\n",
    "variance_data = melted_data.groupby(melted_data.columns[0])['Score'].var()\n",
    "\n",
    "# Compute descriptive statistics\n",
    "mean_variance = variance_data.mean()\n",
    "median_variance = variance_data.median()\n",
    "min_variance = variance_data.min()\n",
    "max_variance = variance_data.max()\n",
    "low_variance_threshold = 0.1\n",
    "low_variance_proportion = (variance_data < low_variance_threshold).mean() * 100\n",
    "\n",
    "# Plot histogram with annotations\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.histplot(variance_data, bins=20, kde=True, color='skyblue')\n",
    "\n",
    "# Add mean and median lines\n",
    "plt.axvline(mean_variance, color='red', linestyle='--', label=f'Mean Variance: {mean_variance:.3f}')\n",
    "plt.axvline(median_variance, color='green', linestyle='--', label=f'Median Variance: {median_variance:.3f}')\n",
    "\n",
    "# Annotate proportion of low variance\n",
    "plt.text(0.5, 10, f\"Low Variance (<{low_variance_threshold}): {low_variance_proportion:.2f}%\", fontsize=10)\n",
    "\n",
    "plt.title('Distribution of Score Variances Across Data Points')\n",
    "plt.xlabel('Variance')\n",
    "plt.ylabel('Frequency')\n",
    "plt.legend()\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Identify data points with low and high variance\n",
    "low_variance_points = variance_data[variance_data < low_variance_threshold].count()\n",
    "high_variance_points = variance_data[variance_data > 0.5].count()\n",
    "\n",
    "\n",
    "# Create a summary DataFrame\n",
    "summary = pd.DataFrame({\n",
    "    'Metric': ['Mean Variance', 'Median Variance', 'Min Variance', 'Max Variance',\n",
    "               'Proportion of Low Variance', 'Low Variance Points', 'High Variance Points'],\n",
    "    'Value': [mean_variance, median_variance, min_variance, max_variance,\n",
    "              f\"{low_variance_proportion:.2f}%\", low_variance_points, high_variance_points]\n",
    "})\n",
    "\n",
    "# Display the table\n",
    "print(summary)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total Transitions: 114\n",
      "Total 0-to-2 Transitions: 8\n",
      "Percent 0-to-2 Transitions: 7.02%\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "\n",
    "# Step 1: Filter high-variance data points\n",
    "high_variance_threshold = 0.5\n",
    "high_variance_points = variance_data[variance_data > high_variance_threshold].index\n",
    "\n",
    "# Step 2: Extract scores for high-variance data points\n",
    "high_variance_scores = melted_data[melted_data[melted_data.columns[0]].isin(high_variance_points)]\n",
    "\n",
    "# Step 3: Group by each data point and calculate transitions\n",
    "total_transitions = 0\n",
    "total_0_to_2_transitions = 0\n",
    "total_2_to_0_transitions = 0\n",
    "\n",
    "for data_point in high_variance_points:\n",
    "    # Get scores for the data point\n",
    "    scores = high_variance_scores[high_variance_scores[melted_data.columns[0]] == data_point]['Score'].values\n",
    "    \n",
    "    # Calculate consecutive transitions\n",
    "    transitions = list(zip(scores[:-1], scores[1:]))\n",
    "    total_transitions += len(transitions)\n",
    "    \n",
    "    # Count 0->2 and 2->0 transitions\n",
    "    total_0_to_2_transitions += transitions.count((0, 2))\n",
    "    total_2_to_0_transitions += transitions.count((2, 0))\n",
    "\n",
    "# Step 4: Compute percentages\n",
    "percent_0_to_2 = (total_0_to_2_transitions / total_transitions) * 100 if total_transitions > 0 else 0\n",
    "percent_2_to_0 = (total_2_to_0_transitions / total_transitions) * 100 if total_transitions > 0 else 0\n",
    "\n",
    "# Print results\n",
    "print(f\"Total Transitions: {total_transitions}\")\n",
    "print(f\"Total 0-to-2 Transitions: {total_0_to_2_transitions}\")\n",
    "print(f\"Percent 0-to-2 Transitions: {percent_0_to_2:.2f}%\")\n",
    "\n",
    "# across all seeds"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Compute mean and standard deviation for each data point\n",
    "stats_data = melted_data.groupby(melted_data.columns[0])['Score'].agg(['mean', 'std']).reset_index()\n",
    "\n",
    "# Sort stats_data by mean scores\n",
    "stats_data_sorted = stats_data.sort_values(by='mean', ascending=True)\n",
    "\n",
    "# Error bar plot with sorted data\n",
    "plt.figure(figsize=(12, 6))\n",
    "plt.errorbar(stats_data_sorted[melted_data.columns[0]], stats_data_sorted['mean'], yerr=stats_data_sorted['std'], fmt='o', ecolor='r', capsize=5)\n",
    "#plt.xticks(rotation=90)\n",
    "plt.xticks([], [])\n",
    "plt.title('Mean Scores with Error Bars (Sorted by Mean)')\n",
    "plt.xlabel('Data Point (Titles)')\n",
    "plt.ylabel('Mean Score')\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import numpy as np\n",
    "\n",
    "# Compute mean and standard deviation for each data point\n",
    "stats_data = melted_data.groupby(melted_data.columns[0])['Score'].agg(['mean', 'std']).reset_index()\n",
    "\n",
    "# Compute the majority vote (mode) for each data point\n",
    "majority_vote = melted_data.groupby(melted_data.columns[0])['Score'].agg(lambda x: x.mode()[0]).reset_index()\n",
    "majority_vote.columns = [melted_data.columns[0], 'Majority Vote']\n",
    "\n",
    "# Merge majority vote with stats_data\n",
    "stats_data = stats_data.merge(majority_vote, on=melted_data.columns[0])\n",
    "\n",
    "# Sort stats_data by mean scores\n",
    "stats_data_sorted = stats_data.sort_values(by='mean', ascending=True)\n",
    "\n",
    "# Error bar plot with majority vote as ground truth\n",
    "plt.figure(figsize=(12, 6))\n",
    "plt.errorbar(\n",
    "    stats_data_sorted[melted_data.columns[0]],\n",
    "    stats_data_sorted['mean'],\n",
    "    yerr=stats_data_sorted['std'],\n",
    "    fmt='o',\n",
    "    ecolor='r',\n",
    "    capsize=5,\n",
    "    label='Mean Scores with Std Dev'\n",
    ")\n",
    "\n",
    "# Overlay majority-voted scores\n",
    "plt.scatter(\n",
    "    stats_data_sorted[melted_data.columns[0]],\n",
    "    stats_data_sorted['Majority Vote'],\n",
    "    color='blue',\n",
    "    marker='x',\n",
    "    s=50,\n",
    "    label='Majority Vote (Ground Truth)'\n",
    ")\n",
    "\n",
    "plt.xticks([], [])\n",
    "plt.title('Mean Scores with Error Bars and Majority Vote (Sorted by Mean)')\n",
    "plt.xlabel('Data Point (Titles)')\n",
    "plt.ylabel('Mean Score')\n",
    "plt.legend()\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mean Standard Deviation: 0.42607078296764306\n",
      "Maximum Standard Deviation: 0.812727700887249\n"
     ]
    }
   ],
   "source": [
    "file_path = './llama_scores.csv'\n",
    "scores = pd.read_csv(file_path)\n",
    "\n",
    "# Extract title and seed scores\n",
    "titles = scores.iloc[:, 0]  # First column (Titles)\n",
    "seed_scores = scores.iloc[:, 1:]  # All other columns (Scores)\n",
    "\n",
    "# Calculate the standard deviation across seeds for each data point\n",
    "scores_std = seed_scores.std(axis=1)\n",
    "\n",
    "# Add standard deviation as a new column to the dataframe\n",
    "scores['Score Std Dev'] = scores_std\n",
    "\n",
    "# Compute mean and max standard deviation\n",
    "mean_std_dev = scores_std.mean()\n",
    "max_std_dev = scores_std.max()\n",
    "\n",
    "print(f\"Mean Standard Deviation: {mean_std_dev}\")\n",
    "print(f\"Maximum Standard Deviation: {max_std_dev}\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Seed Accuracies:\n",
      "      Seed  Accuracy\n",
      "9   332104  0.861538\n",
      "0       42  0.846154\n",
      "2    11878  0.846154\n",
      "14  998553  0.830769\n",
      "1      123  0.830769\n",
      "3   659957  0.800000\n",
      "5   662817  0.800000\n",
      "6   704703  0.769231\n",
      "12  439967  0.753846\n",
      "10  520166  0.753846\n",
      "4   826888  0.753846\n",
      "19   39517  0.753846\n",
      "8   668517  0.738462\n",
      "13  259183  0.738462\n",
      "11  995273  0.707692\n",
      "17  434022  0.707692\n",
      "16  916101  0.692308\n",
      "7    68962  0.676923\n",
      "18  135613  0.661538\n",
      "15  283205  0.615385\n"
     ]
    }
   ],
   "source": [
    "# Example: Compute majority vote for each data point\n",
    "majority_vote = seed_scores.mode(axis=1)[0]\n",
    "\n",
    "# Calculate seed accuracy against majority vote\n",
    "seed_accuracies = {}\n",
    "for seed in seed_scores.columns:\n",
    "    seed_accuracies[seed] = (seed_scores[seed] == majority_vote).mean()\n",
    "\n",
    "# Convert to DataFrame for analysis\n",
    "seed_accuracies_df = pd.DataFrame(list(seed_accuracies.items()), columns=['Seed', 'Accuracy'])\n",
    "seed_accuracies_df.sort_values(by='Accuracy', ascending=False, inplace=True)\n",
    "\n",
    "print(\"Seed Accuracies:\")\n",
    "print(seed_accuracies_df)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Category Distribution Per Paper:\n",
      "    Score_0  Score_1  Score_2\n",
      "0       0.0     16.0      4.0\n",
      "1       4.0     13.0      3.0\n",
      "2       7.0     11.0      2.0\n",
      "3      10.0     10.0      0.0\n",
      "4      17.0      3.0      0.0\n",
      "..      ...      ...      ...\n",
      "60     20.0      0.0      0.0\n",
      "61     15.0      5.0      0.0\n",
      "62      0.0      3.0     17.0\n",
      "63      7.0     10.0      3.0\n",
      "64     12.0      5.0      3.0\n",
      "\n",
      "[65 rows x 3 columns]\n",
      "\n",
      "Majority Score and Agreement:\n",
      "                                                Title  Majority Score  \\\n",
      "0   Repeated Exercise Induces Release of Soluble P...             1.0   \n",
      "1   Should Claudicants Receive Angioplasty or Exer...             1.0   \n",
      "2   Intermittent claudication should not be treate...             1.0   \n",
      "3   Exercise and nursing therapy for patients with...             0.0   \n",
      "4   Treatment of intermittent claudication with ph...             0.0   \n",
      "..                                                ...             ...   \n",
      "60  Assessment and management of acute pain in hig...             0.0   \n",
      "61  DAILY COST PREDICTION MODEL IN NEONATAL INTENS...             0.0   \n",
      "62  Impact of bronchopulmonary dysplasia, brain in...             2.0   \n",
      "63  Indomethacin for asymptomatic patent ductus ar...             1.0   \n",
      "64  Management of Patent Ductus Arteriosus in Very...             0.0   \n",
      "\n",
      "    Agreement with Majority (%)  \n",
      "0                          80.0  \n",
      "1                          65.0  \n",
      "2                          55.0  \n",
      "3                          50.0  \n",
      "4                          85.0  \n",
      "..                          ...  \n",
      "60                        100.0  \n",
      "61                         75.0  \n",
      "62                         85.0  \n",
      "63                         50.0  \n",
      "64                         60.0  \n",
      "\n",
      "[65 rows x 3 columns]\n",
      "\n",
      "Transition Patterns (Sum of Absolute Score Changes):\n",
      "                                                Title  Score Transitions\n",
      "0   Repeated Exercise Induces Release of Soluble P...                4.0\n",
      "1   Should Claudicants Receive Angioplasty or Exer...               14.0\n",
      "2   Intermittent claudication should not be treate...               12.0\n",
      "3   Exercise and nursing therapy for patients with...               12.0\n",
      "4   Treatment of intermittent claudication with ph...                6.0\n",
      "..                                                ...                ...\n",
      "60  Assessment and management of acute pain in hig...                0.0\n",
      "61  DAILY COST PREDICTION MODEL IN NEONATAL INTENS...                6.0\n",
      "62  Impact of bronchopulmonary dysplasia, brain in...                5.0\n",
      "63  Indomethacin for asymptomatic patent ductus ar...               15.0\n",
      "64  Management of Patent Ductus Arteriosus in Very...                9.0\n",
      "\n",
      "[65 rows x 2 columns]\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "file_path = './llama_scores.csv'\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "# Load data\n",
    "data = pd.read_csv(file_path)\n",
    "\n",
    "# Extract titles and scores\n",
    "titles = data.iloc[:, 0]  # First column (Titles)\n",
    "scores = data.iloc[:, 1:]  # Remaining columns (Scores)\n",
    "\n",
    "# 1. Category Distribution per Paper\n",
    "category_counts = scores.apply(lambda row: row.value_counts(), axis=1).fillna(0)\n",
    "category_counts.columns = [f\"Score_{int(col)}\" for col in category_counts.columns]\n",
    "print(\"\\nCategory Distribution Per Paper:\")\n",
    "print(category_counts)\n",
    "\n",
    "# 2. Majority Score\n",
    "mode_scores = scores.mode(axis=1)[0]  # Extract mode for each row (paper)\n",
    "agreement_with_mode = scores.apply(lambda row: (row == mode_scores[row.name]).mean(), axis=1)\n",
    "\n",
    "print(\"\\nMajority Score and Agreement:\")\n",
    "majority_stats = pd.DataFrame({\n",
    "    'Title': titles,\n",
    "    'Majority Score': mode_scores,\n",
    "    'Agreement with Majority (%)': agreement_with_mode * 100\n",
    "})\n",
    "print(majority_stats)\n",
    "\n",
    "\n",
    "# 3. Transition Patterns\n",
    "transitions = scores.apply(lambda row: row.diff().fillna(0).abs().sum(), axis=1)\n",
    "print(\"\\nTransition Patterns (Sum of Absolute Score Changes):\")\n",
    "transition_stats = pd.DataFrame({\n",
    "    'Title': titles,\n",
    "    'Score Transitions': transitions\n",
    "})\n",
    "print(transition_stats)\n",
    "\n",
    "# 4. Heatmap Visualization\n",
    "plt.figure(figsize=(12, 8))\n",
    "sns.heatmap(scores, cmap=\"coolwarm\", annot=False, cbar=True, xticklabels=False, yticklabels=False)\n",
    "plt.title(\"Heatmap of Scores Across Random Seeds\")\n",
    "plt.xlabel(\"Seeds\")\n",
    "plt.ylabel(\"Paper Titles\")\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Summary of Results\n",
    "\n",
    "- **Category Distribution**: Papers with consistent scores (e.g., \"Bipolar affective disorder\") show high frequency for a single score, while others like \"Poor outcome of very low birthweight babies\" have a more balanced distribution, indicating variability in assessments.\n",
    "\n",
    "- **Majority Score and Agreement**: Most papers exhibit high agreement with their majority score, with some papers (e.g., \"Bipolar affective disorder\") showing perfect consistency, while others (e.g., \"The management of chronic lung disease\") have lower agreement, suggesting variability.\n",
    "\n",
    "- **Transition Patterns**: Papers with 0 transitions (e.g., \"Bipolar affective disorder\") show stable scores across seeds, while others with high transitions (e.g., \"Poor outcome of very low birthweight babies\") exhibit significant score variability.\n",
    "\n",
    "- **Heatmap**: Stable papers appear with uniform color rows (consistent scores), while varied papers show mixed colors, reflecting inconsistency across runs.\n",
    "\n",
    "This analysis suggests that most papers show consistent results, but some exhibit notable variability, indicating areas where the model's performance could be improved."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Fleiss' Kappa Score: 0.4307710074698494\n"
     ]
    }
   ],
   "source": [
    "from statsmodels.stats.inter_rater import fleiss_kappa\n",
    "import numpy as np\n",
    "\n",
    "# Prepare the data for Fleiss' Kappa: count how often each score (0, 1, 2) appears for each paper across all seeds\n",
    "score_counts = scores.apply(lambda row: [sum(row == 0), sum(row == 1), sum(row == 2)], axis=1)\n",
    "\n",
    "score_counts_array = np.array(score_counts.tolist(), dtype=int)\n",
    "\n",
    "fleiss_kappa_value = fleiss_kappa(score_counts_array)\n",
    "print(f\"Fleiss' Kappa Score: {fleiss_kappa_value}\") # moderately consistent \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7.826086956521739"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "transitions.mean()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>42</th>\n",
       "      <th>123</th>\n",
       "      <th>11878</th>\n",
       "      <th>659957</th>\n",
       "      <th>826888</th>\n",
       "      <th>662817</th>\n",
       "      <th>704703</th>\n",
       "      <th>68962</th>\n",
       "      <th>668517</th>\n",
       "      <th>...</th>\n",
       "      <th>520166</th>\n",
       "      <th>995273</th>\n",
       "      <th>439967</th>\n",
       "      <th>259183</th>\n",
       "      <th>998553</th>\n",
       "      <th>283205</th>\n",
       "      <th>916101</th>\n",
       "      <th>434022</th>\n",
       "      <th>135613</th>\n",
       "      <th>39517</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1. Repeated Exercise Induces Release of Solubl...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2. Should Claudicants Receive Angioplasty or E...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3. Intermittent claudication should not be tre...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1. Should Claudicants Receive Angioplasty or J...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2. Angioplasty (versus non surgical management...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1. Exercise and nursing therapy for patients w...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>...</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>2. Treatment of intermittent claudication with...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>3. Outcome of femoropopliteal angioplasty</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>4. Outcome of the first 100 femoropopliteal an...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1. Exercise and nursing therapy for patients w...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>2. Treatment of intermittent claudication with...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>3. Outcome of femoropopliteal angioplasty.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>4. Outcome of the first 100 femoropopliteal an...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>2. Angioplasty (versus non surgical management...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>14 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                title   42  123  11878  \\\n",
       "0   1. Repeated Exercise Induces Release of Solubl...  2.0  1.0    1.0   \n",
       "1   2. Should Claudicants Receive Angioplasty or E...  1.0  1.0    1.0   \n",
       "2   3. Intermittent claudication should not be tre...  0.0  0.0    1.0   \n",
       "3   1. Should Claudicants Receive Angioplasty or J...  1.0  0.0    1.0   \n",
       "4   2. Angioplasty (versus non surgical management...  0.0  0.0    NaN   \n",
       "5   1. Exercise and nursing therapy for patients w...  0.0  NaN    0.0   \n",
       "6   2. Treatment of intermittent claudication with...  0.0  NaN    0.0   \n",
       "7           3. Outcome of femoropopliteal angioplasty  2.0  NaN    2.0   \n",
       "8   4. Outcome of the first 100 femoropopliteal an...  2.0  NaN    1.0   \n",
       "9   1. Exercise and nursing therapy for patients w...  NaN  1.0    NaN   \n",
       "10  2. Treatment of intermittent claudication with...  NaN  0.0    NaN   \n",
       "11         3. Outcome of femoropopliteal angioplasty.  NaN  2.0    NaN   \n",
       "12  4. Outcome of the first 100 femoropopliteal an...  NaN  2.0    NaN   \n",
       "13  2. Angioplasty (versus non surgical management...  NaN  NaN    0.0   \n",
       "\n",
       "    659957  826888  662817  704703  68962  668517  ...  520166  995273  \\\n",
       "0      1.0     2.0     1.0     1.0    1.0     1.0  ...     1.0     1.0   \n",
       "1      0.0     1.0     1.0     2.0    0.0     1.0  ...     1.0     1.0   \n",
       "2      2.0     0.0     0.0     1.0    1.0     0.0  ...     1.0     1.0   \n",
       "3      0.0     1.0     0.0     0.0    0.0     1.0  ...     1.0     NaN   \n",
       "4      0.0     NaN     NaN     0.0    0.0     0.0  ...     NaN     NaN   \n",
       "5      NaN     0.0     0.0     1.0    0.0     1.0  ...     1.0     1.0   \n",
       "6      NaN     1.0     0.0     1.0    0.0     0.0  ...     0.0     0.0   \n",
       "7      NaN     2.0     2.0     2.0    1.0     2.0  ...     2.0     2.0   \n",
       "8      NaN     2.0     2.0     2.0    1.0     2.0  ...     2.0     1.0   \n",
       "9      1.0     NaN     NaN     NaN    NaN     NaN  ...     NaN     NaN   \n",
       "10     0.0     NaN     NaN     NaN    NaN     NaN  ...     NaN     NaN   \n",
       "11     2.0     NaN     NaN     NaN    NaN     NaN  ...     NaN     NaN   \n",
       "12     2.0     NaN     NaN     NaN    NaN     NaN  ...     NaN     NaN   \n",
       "13     NaN     0.0     0.0     NaN    NaN     NaN  ...     0.0     NaN   \n",
       "\n",
       "    439967  259183  998553  283205  916101  434022  135613  39517  \n",
       "0      1.0     1.0     1.0     1.0     1.0     1.0     2.0    2.0  \n",
       "1      1.0     2.0     1.0     0.0     2.0     1.0     0.0    1.0  \n",
       "2      1.0     0.0     1.0     0.0     1.0     1.0     1.0    2.0  \n",
       "3      1.0     0.0     1.0     1.0     1.0     0.0     1.0    0.0  \n",
       "4      0.0     0.0     0.0     NaN     0.0     NaN     NaN    0.0  \n",
       "5      1.0     1.0     1.0     NaN     1.0     0.0     NaN    0.0  \n",
       "6      0.0     0.0     0.0     NaN     0.0     0.0     NaN    0.0  \n",
       "7      2.0     1.0     2.0     NaN     2.0     2.0     NaN    1.0  \n",
       "8      2.0     1.0     2.0     NaN     2.0     2.0     NaN    1.0  \n",
       "9      NaN     NaN     NaN     0.0     NaN     NaN     0.0    NaN  \n",
       "10     NaN     NaN     NaN     0.0     NaN     NaN     1.0    NaN  \n",
       "11     NaN     NaN     NaN     0.0     NaN     NaN     2.0    NaN  \n",
       "12     NaN     NaN     NaN     0.0     NaN     NaN     2.0    NaN  \n",
       "13     NaN     NaN     NaN     0.0     NaN     0.0     0.0    NaN  \n",
       "\n",
       "[14 rows x 21 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "### Consistency input data creation\n",
    "\n",
    "import json\n",
    "import pandas as pd\n",
    "\n",
    "# read json \n",
    "with open(\"../llama_outputs_CD000017_log_p1.json\") as f:\n",
    "    data = json.load(f)\n",
    "\n",
    "title_dict = {}\n",
    "\n",
    "for entry in data:\n",
    "    seed = entry['seed']\n",
    "    llama_output = entry.get('llama_output', {})\n",
    "    paper_list = llama_output.get('paper_list', {})\n",
    "    \n",
    "    # Process each title and store relevance scores with seeds\n",
    "    for title, details in paper_list.items():\n",
    "        if title not in title_dict:\n",
    "            title_dict[title] = {}\n",
    "        title_dict[title][seed] = details.get('relevance', 0)\n",
    "\n",
    "# Convert the dictionary into a DataFrame\n",
    "df = pd.DataFrame.from_dict(title_dict, orient='index').reset_index()\n",
    "\n",
    "# Rename the first column to 'title'\n",
    "df.rename(columns={'index': 'title'}, inplace=True)\n",
    "\n",
    "\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv('CD000017_p1.csv', index=False)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "scigen",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
